Omnicell (OMCL) 10-Q 6 May 16 2016 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2016	Apr. 29, 2016
Entity [Abstract]
Entity Registrant Name	OMNICELL, Inc
Entity Central Index Key	926,326
Document Type	10-Q
Document Period End Date	Mar. 31, 2016
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		35,917,793
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q1

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 53,487	$ 82,217
Accounts receivable, net of allowances of $1,224 and $1,240, respectively	153,199	107,957
Inventories	71,914	46,594
Prepaid expenses	21,855	19,586
Other current assets	9,853	7,774
Total current assets	310,308	264,128
Property and equipment, net	42,208	32,309
Long-term investment in sales-type leases, net	21,037	14,484
Goodwill	312,511	147,906
Intangible assets, net	206,261	89,665
Long-term deferred tax assets	2,638	2,361
Other long-term assets	28,809	27,894
Total assets	923,772	578,747
Current liabilities:
Accounts payable	32,142	22,646
Accrued compensation	31,918	18,195
Accrued liabilities	34,903	30,133
Long-term debt, current portion, net	8,410	0
Deferred revenue, net	92,273	53,656
Total current liabilities	199,646	124,630
Long-term, deferred revenue	17,820	17,975
Long-term deferred tax liabilities	64,984	21,822
Other long-term liabilities	11,771	11,932
Long-term debt, net	219,046	0
Total liabilities	$ 513,267	$ 176,359
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.001 par value, 5,000 shares authorized; no shares issued	$ 0	$ 0
Common stock, $0.001 par value, 100,000 shares authorized; 45,010 and 44,739 shares issued; 35,865, and 35,594 shares outstanding, respectively	45	45
Treasury stock at cost, 9,145 shares outstanding	(185,074)	(185,074)
Additional paid-in capital	499,176	490,354
Retained earnings	99,415	99,793
Accumulated other comprehensive loss	(3,057)	(2,730)
Total stockholders’ equity	410,505	402,388
Total liabilities and stockholders’ equity	$ 923,772	$ 578,747

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets Parenthetical - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Statement of Financial Position [Abstract]
Allowances	$ 1,224	$ 1,240
Preferred Stock, Par Value (in dollars per share)	$ 0.001	$ 0.001
Preferred Stock, Shares, Authorized	5,000,000	5,000,000
Common Stock, Par Value (in dollars per share)	$ 0.001	$ 0.001
Common Stock, Shares, Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	45,010,000	44,739,000
Common Stock, Shares, Outstanding	35,865,000	35,594,000
Treasury Stock, Shares	9,145,000	9,145,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Revenues:
Product	$ 127,895	$ 94,109
Services and other revenues	43,109	22,112
Total revenues	171,004	116,221
Cost of revenues:
Cost of product revenues	71,918	45,416
Cost of services and other revenues	19,141	9,120
Total cost of revenues	91,059	54,536
Gross profit	79,945	61,685
Operating expenses:
Research and development	13,838	8,019
Selling, general and administrative	64,255	43,287
Total operating expenses	78,093	51,306
Income from operations	1,852	10,379
Other income (expense), net	(2,171)	(517)
Income (loss) before provision for income taxes	(319)	9,862
Provision for income taxes	59	3,544
Net (loss) income	$ (378)	$ 6,318
Net (loss) income per share:
Basic (in dollars per share)	$ (0.01)	$ 0.18
Diluted (in dollars per share)	$ (0.01)	$ 0.17
Weighted-average shares outstanding:
Basic (in shares)	35,740	36,024
Diluted (in shares)	35,740	36,914

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Statement of Comprehensive Income [Abstract]
Net (loss) income	$ (378)	$ 6,318
Other comprehensive loss, net of reclassification adjustments:
Foreign currency translation adjustments, net of tax	(327)	(877)
Other comprehensive loss	(327)	(877)
Comprehensive (loss) income	$ (705)	$ 5,441

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Operating Activities
Net (loss) income	$ (378)	$ 6,318
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	14,473	5,711
Loss on disposal of fixed assets	13	4
Provision for receivable allowance	92	281
Share-based compensation expense	3,891	3,665
Income tax benefits from employee stock plans	164	822
Excess tax benefits from employee stock plans	(220)	(1,151)
Provision for excess and obsolete inventories	248	270
Deferred income taxes	(1,042)	361
Amortization of debt financing fees	397	0
Changes in operating assets and liabilities:
Accounts receivable, net	(1,162)	(5,631)
Inventories	(5,361)	(1,906)
Prepaid expenses	1,983	6,707
Other current assets	324	1,124
Investment in sales-type leases, net	(8,928)	285
Other long-term assets	1,232	(85)
Accounts payable	1,568	2,200
Accrued compensation	4,114	(2,810)
Accrued liabilities	417	2,718
Deferred revenue	12,663	(6,557)
Other long-term liabilities	(2,701)	(1,012)
Net cash provided by operating activities	21,787	11,314
Investing Activities
Purchases of intangible assets, intellectual property, and patents	(1,074)	(103)
Software development for external use	(3,070)	(2,957)
Purchases of property and equipment	(4,261)	(1,048)
Business acquisitions, net of cash acquired	(271,458)	0
Net cash used in investing activities	(279,863)	(4,108)
Financing Activities
Proceeds from debt, net	247,059	0
Repayment of debt under revolving credit facility	(20,000)	0
Payment for contingent consideration	(3,000)	0
Proceeds from issuances under stock-based compensation plans	5,149	6,224
Employees' taxes paid related to restricted stock units	(382)	(800)
Excess tax benefits from employee stock plans	220	1,151
Net cash provided by financing activities	229,046	6,575
Effect of exchange rate changes on cash and cash equivalents	300	(116)
Net (decrease) increase in cash and cash equivalents	(28,730)	13,665
Cash and cash equivalents at beginning of period	82,217	125,888
Cash and cash equivalents at end of period	$ 53,487	$ 139,553

Organization and Summary of Sig

Organization and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2016
Accounting Policies [Abstract]
Organization and Summary of Significant Accounting Policies	Organization and Summary of Significant Accounting Policies Business Omnicell, Inc. was incorporated in California in 1992 under the name Omnicell Technologies, Inc. and reincorporated in Delaware in 2001 as Omnicell, Inc. Our major products are automated medication, supply control systems and medication adherence solutions which are sold in our principal market, which is the healthcare industry. Our market is primarily located in the United States and Europe. "Omnicell" "our", "us", "we" or the "Company" collectively refer to Omnicell, Inc. and its subsidiaries. Basis of presentation The accompanying unaudited Condensed Consolidated Financial Statements reflect, in the opinion of management, all adjustments, consisting of normal recurring adjustments and accruals, necessary to present fairly the financial position of the Company as of March 31, 2016 and December 31, 2015 , the results of their operations, comprehensive income (loss) and cash flows for the three months ended March 31, 2016 and March 31, 2015 . Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and accompanying Notes included in the Company's annual report on Form 10-K for the year ended December 31, 2015 filed with the SEC on February 26, 2016. The Company's results of operations, comprehensive income (loss) and cash flows for the three months ended March 31, 2016 are not necessarily indicative of results that may be expected for the year ending December 31, 2016 , or for any future period. Principles of consolidation The Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. On January 5, 2016, the Company completed the acquisition of all of the membership interests of Aesynt Holding Coöperatief U.A. ("Aesynt"). The significant accounting policies of Aesynt have been aligned to conform to those accounting policies of Omnicell, and the consolidated financial statements include the results of operations of Aesynt commencing as of the acquisition date. Use of estimates The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company's Condensed Consolidated Financial Statements and accompanying Notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management's best knowledge of current events and actions that may impact the Company in the future, actual results may be different from the estimates. The Company's critical accounting policies are those that affect its financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, share-based compensation, inventory valuation, accounts receivable and notes receivable (investment in sales-type leases), capitalized software development costs, valuation of goodwill and purchased intangibles and long-lived assets, fair value of assets acquired and liabilities assumed in business combinations, and accounting for income taxes. Segment reporting change The Company's Chief Operating Decision Maker ("CODM") is its Chief Executive Officer. The CODM allocates resources and evaluates the performance of the Company's segments using information about its revenues, gross profit, and income from operations. Such evaluation excludes general corporate-level costs that are not specific to either of the reportable segments and are managed separately at the corporate level. Corporate-level costs include expenses related to executive management, finance and accounting, human resources, legal, training and development, and certain administrative expenses. The operating results of the recently acquired Aesynt business is included in the Company's Automation and Analytics reporting segment. Concentration of credit risk Financial instruments that may potentially subject the Company to concentrations of credit risk consist principally of cash equivalents and accounts receivable. Cash equivalents are maintained with several financial institutions and may exceed the amount of insurance provided on such balances. The majority of the Company's accounts receivable are derived from sales to customers for commercial applications. The Company performs ongoing credit evaluations of its customers’ financial condition and limit the amount of credit extended when deemed necessary but generally require no collateral. The Company maintains reserves for potential credit losses. The Company's products are broadly distributed and there were no customers that accounted for more than 10% of its accounts receivable as of March 31, 2016 and December 31, 2015 . The Company believes that it has no significant concentrations of credit risk as of March 31, 2016 . Recently adopted authoritative guidance In July 2015, the FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory. The new guidance changes the measurement principle for inventory from the lower of cost or market to lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. It applies to entities that measure inventory using a method other than last-in, first-out (LIFO) and the retail inventory method (RIM). The new guidance is effective for fiscal years beginning after December 15, 2016. The adoption of this accounting standard update did not have a material impact on the Company's consolidated financial position or results of operations for the three months ended March 31, 2016. In September 2015, the FASB issued ASU No. 2015-16, Business Combinations (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments ("ASU 2015-16"). This ASU requires adjustments to provisional amounts that are identified during the measurement period of a business combination to be recognized in the reporting period in which the adjustment amounts are determined. An acquirer is no longer required to revise comparative information for prior periods as if the accounting for the business combination had been completed as of the acquisition date. The provisions of ASU 2015-16 are effective for reporting periods beginning after December 15, 2015. The adoption of this accounting standard update did not have any impact on the Company's consolidated financial position or results of operations for the three months ended March 31, 2016. Recently issued authoritative guidance In March 2016, the FASB issued ASU No. 2016-09, Compensation—Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. This ASU simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. The provision of ASU No. 2016-09 are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted for any entity in any interim or annual period. If an entity early adopts the amendments in an interim period, any adjustments are reflected as of the beginning of the fiscal year that includes that interim period. An entity that elects early adoption must adopt all of the amendments in the same period. The Company is currently in the process of evaluating the impact of the adoption of ASU 2016-09 on its consolidated financial statements. There was no other recently issued authoritative guidance that has a material impact on our Condensed Consolidated Financial Statements through the reporting date.

Business Acquisitions

Business Acquisitions	3 Months Ended
	Mar. 31, 2016
Business Combinations [Abstract]
Business Acquisitions	Business Acquisitions 2016 Acquisition On January 5, 2016, the Company completed the acquisition of all of the membership interests of Aesynt pursuant to the Securities Purchase Agreement for total cash consideration of $271.5 million , net of cash on hand at signing of $8.2 million . Aesynt is a provider of automated medication management systems, including dispensing robots with storage solutions, medication storage and dispensing carts and cabinets, I.V. sterile preparation robotics and software, including software related to medication management. The Company accounted for the purchase of Aesynt in accordance with the authoritative guidance on business combinations; therefore, the tangible and intangible assets acquired and liabilities assumed were recorded at fair value on the acquisition date. The following table represents the preliminary estimated allocation of the purchase price to the assets acquired and the liabilities assumed by the Company, reconciled to the purchase price transferred included in the Company's Condensed Consolidated Balance Sheet: (In thousands) Cash $ 8,164 Accounts receivable 44,895 Inventory 20,111 Other current assets 4,381 Total current assets 77,551 Property and equipment 10,389 Intangible assets 123,700 Goodwill 164,824 Other non-current assets 968 Total assets 377,432 Current liabilities 25,821 Deferred revenue, net 25,631 Non-current deferred tax liabilities 43,927 Other non-current liabilities 2,431 Total liabilities 97,810 Total purchase price 279,622 Total purchase price, net of cash received $ 271,458 The goodwill arising from this acquisition is primarily attributed to sales of future products and services and the assembled workforce of Aesynt. The Aesynt acquisition would create the broadest product portfolio in the industry with significant offerings in automated dispensing systems, central pharmacy robotics, IV robotics and enterprise analytics. Goodwill has been assigned to the Automation & Analytics segment and is not deductible for tax purposes. Goodwill is not being amortized but is reviewed annually for impairment or more frequently if impairment indicators arise, in accordance with authoritative guidance. Identifiable intangible assets (preliminary) acquired and their respective estimated remaining useful lives over which each asset will be amortized areas are as follows: Fair value Weighted (In thousands) (In years) Customer relationships $ 58,200 14-16 Developed technology 38,800 8 Backlog 20,200 1-3 In-process R&D (1) 3,900 - Non-compete 1,800 3 Trade names 800 1 Total purchased intangible assets $ 123,700 (1) The amortization of the IPR&D assets begin when the IPR&D projects are complete. Customer relationships represent the fair value of the underlying relationships and agreements with Aesynt’s customers, acquired developed technology represents the fair value of Aesynt products that have reached technological feasibility and were part of Aesynt’s product offerings at the date of acquisition, backlog represents the fair value of sales order backlog at the date of acquisition, non-compete intangible asset represents the fair value of non-compete agreements with former key members of Aesynt's management, and trade name represents the fair value of brand and name recognition associated with the marketing of Aesynt’s products and services. In-process research and development ("IPR&D") represents the fair value of incomplete Aesynt R&D projects that had not reached technological feasibility as of the date of acquisition. Incremental costs incurred for those projects are expensed as incurred in R&D. The fair value of trade names, acquired developed technology, and acquired IPR&D was determined based on an income approach using the relief-from-royalty method at the royalty rates of 0.5% , 4%-8% and 12.5% , respectively. The fair value of customer relationships, backlog, and non-compete intangible assets was determined based on an income approach using the discounted cash flow method, at the discounted rates of 13% , 10% and 13% , respectively. The intangible assets, except customer relationship and IPR&D, are being amortized over their estimated useful lives using the straight line method of amortization. The customer relationship intangible asset is being amortized using a double-declining method of amortization as such method better represents the economic benefits to be obtained. In accordance with authoritative guidance, the IPR&D is accounted for as an indefinite-lived intangible asset until completion or abandonment of the associated research and development efforts. IPR&D is tested for impairment during the period it is considered an indefinite lived asset. IPR&D related projects are expected to be completed in two to three years. The Company incurred approximately $5.2 million in acquisition-related costs related to the Aesynt acquisition of which $2.9 million and $2.3 million was recognized in three months ended December 31, 2015 and March 31, 2016 , respectively. These costs are included in selling, general and administrative expenses in the Company's Condensed Consolidated Statement of Operations. Aesynt generated revenue of $43.2 million and losses from operations of $9.5 million since the acquisition date through March 31, 2016. Pro forma financial information for 2016 and 2015 acquisitions The following table presents certain unaudited pro forma information for illustrative purposes only, for the first quarter of fiscal 2016 and 2015 as if Aesynt had been acquired on January 1, 2015. The pro forma information is not indicative of what would have occurred had the acquisitions taken place on January 1, 2015. The unaudited pro forma information combines the historical results of the acquisitions with the Company's consolidated historical results and includes certain adjustments reflecting the estimated impact of fair value adjustments for the respective periods. The pro forma adjustments include the impact of fair value adjustment related to deferred revenue, inventory fair value adjustment, amortization of intangible assets, stock-based compensation expense, interest expense and amortization of deferred issuance cost, and certain classification to conform to Omnicell's accounting policies. Three months ended March 31, 2016 2015 (In thousands, except per share data) Pro forma net revenues $ 171,004 $ 159,614 Pro forma net income (loss) $ (378 ) $ (119 ) Pro forma net income per share basic $ (0.01 ) $ 0.00 Pro forma net income per share diluted $ (0.01 ) $ 0.00 2015 Acquisitions On April 21, 2015, the Company completed the acquisition of Mach4 Automatisierungstechnik GmbH ("Mach4"), a privately held German limited liability company with its registered office in Bochum, Germany pursuant to a share purchase agreement (the “Mach4 Agreement”), under which Omnicell International, Inc., a wholly-owned subsidiary of Omnicell Inc., purchased the entire issued share capital of Mach4. Pursuant to the terms of Mach4 Agreement, the Company paid approximately $17.3 million in cash, of which $2.7 million was placed in an escrow fund to be distributed to Mach4's former stockholders within 18 months after the closing date of the transaction, subject to indemnification and other claims the Company may make. On April 30, 2015, the Company completed the acquisition of Avantec Healthcare Limited ("Avantec"), the privately-held distributor of Omnicell’s products in the United Kingdom, pursuant to a share purchase agreement (the "Avantec Agreement"), wherein the Company acquired the remaining 85% of issued and outstanding ordinary shares of Avantec was not previously owned by the Company. Pursuant to the terms of the Avantec Agreement, the Company agreed to pay $12.0 million in cash and potential earn-out payments of up to $3.0 million payable after December 31, 2015 and an additional $3.0 million payable after December 31, 2016, based on future bookings. The fair value of these potential earn-out payments as of the acquisition date was $5.6 million . Pursuant to the terms of the Avantec Agreement, the Company retained $1.8 million of the purchase consideration to be held for settlement of any future indemnification claims within an 18 month period that the Company may make following the closing of the transaction. The fair value of the contingent consideration liability related to Avantec is revalued at each reporting date or more frequently if circumstances dictate. Changes in the fair value of this obligation are recorded as income or expense within other expense in our condensed consolidated statements of operation. The significant unobservable inputs used in the fair value measurement of the contingent consideration are the achievement of booking targets and the discount rate. Significant increases or decreases in any of those inputs in isolation would result in a significantly lower or higher fair value measurement. During the three months ended March 31, 2016, the Company paid a $3.0 million earn-out payment which was due after December 31, 2015 based on the achievement of certain metrics set forth in the Avantec Agreement. The Company accounted for the acquisitions above in accordance with the authoritative guidance on business combinations; therefore, the tangible and intangible assets acquired and liabilities assumed were recorded at fair value on the respective acquisition dates. The purchase price allocations are subject to certain post-closing working capital adjustments for the acquired current assets and current liabilities of both acquisitions at their respective acquisition dates. The total consideration and the allocation of consideration to the individual net assets is preliminary, as there are remaining uncertainties to be resolved, including the settlement of the final net working capital adjustment for each. The following table represents the preliminary estimated allocation of the purchase price to the assets acquired and the liabilities assumed by the Company as part of each acquisition: Mach4 Avantec Total (In thousands) Cash $ 397 $ 3,392 $ 3,789 Accounts receivable 3,743 3,607 7,350 Inventory 3,580 1,428 5,008 Deferred tax assets and other current assets 368 89 457 Total current assets 8,088 8,516 16,604 Property and equipment 463 — 463 Intangibles 7,710 6,341 14,051 Goodwill 10,591 15,606 26,197 Other non-current assets 52 — 52 Total assets 26,904 30,463 57,367 Current liabilities 3,684 4,125 7,809 Non-current deferred tax liabilities 2,564 1,269 3,833 Deferred service revenue and gross profit 2,314 928 3,242 Other non-current liabilities 1,056 — 1,056 Total purchase price 17,286 24,141 41,427 Total purchase price, net of cash received $ 16,889 $ 20,749 $ 37,638 Intangible assets acquired and their respective estimated remaining useful lives over which each asset will be amortized are as follows: Mach4 Avantec Fair value Weighted Fair value Weighted average useful life (In thousands) (In years) (In thousands) (In years) Developed technology $ 3,290 8 $ — — Trade name 850 6 92 2 Customer relationships 3,570 10 5,834 12 Backlog — — 415 2 Total purchased intangible assets $ 7,710 $ 6,341 Total revenues for Mach4 and Avantec recorded in the first quarter of 2016 were $3.8 million and $2.9 million , respectively. Total operating loss for Mach4 in the first quarter of 2016 was $1.7 million and total operating income for Avantec in the first quarter of 2016 was $0.8 million . Pro forma results of operations for these acquisitions have not been presented because they are not material to the consolidated results of operations, either individually or in aggregate.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	3 Months Ended
	Mar. 31, 2016
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	Net Income (Loss) Per Share Basic net income (loss) per share is computed by dividing net income for the period by the weighted-average number of shares outstanding during the period. Diluted net income per share is computed by dividing net income for the period by the weighted-average number of shares, less shares repurchased, plus, if dilutive, potential common stock outstanding during the period. Potential common stock includes the effect of outstanding dilutive stock options, restricted stock awards and restricted stock units computed using the treasury stock method. The anti-dilutive weighted-average dilutive shares related to stock award plans are excluded from the computation of the diluted net income per share because their effect would have been anti-dilutive. The calculation of basic and diluted net income (loss) per share is as follows: Three months ended March 31, 2016 2015 (In thousands, except per share data) Net income (loss) $ (378 ) $ 6,318 Weighted-average shares outstanding — basic 35,740 36,024 Effect of dilutive securities from stock award plans — 890 Weighted-average shares outstanding — diluted $ 35,740 $ 36,914 Net income (loss) per share — basic $ (0.01 ) $ 0.18 Net income (loss) per share — diluted $ (0.01 ) $ 0.17 Anti-dilutive weighted-average shares related to stock award plans 2,045 484

Cash and Cash Equivalents and F

Cash and Cash Equivalents and Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2016
Fair Value Disclosures [Abstract]
Cash and Cash Equivalents and Fair Value of Financial Instruments	Cash and Cash Equivalents and Fair Value of Financial Instruments Cash and cash equivalents as of March 31, 2016 and December 31, 2015 include cash and money market funds, which have original maturities of three months or less. Due to the short duration to maturity, the carrying value of such financial instruments approximates the estimated fair value. The cash and cash equivalents at March 31, 2016 and December 31, 2015 were as follows: March 31, December 31, 2015 (In thousands) Cash $ 43,369 $ 72,103 Money market fund 10,118 10,114 Total cash and cash equivalents $ 53,487 $ 82,217 Fair value hierarchy The Company measures its financial instruments at fair value. The Company’s cash equivalents are classified within Level 1 of the fair value hierarchy as they are valued primarily using quoted market prices utilizing market observable inputs. The Company's foreign currency contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments. The Company's contingent consideration liability is classified as Level 3 as valuation inputs are unobservable in the market and significant to the instrument’s valuation. The following table represents the fair value hierarchy of the Company’s financial assets and financial liabilities measured at fair value as of March 31, 2016 : Level 1 Level 2 Level 3 Total (In thousands) Money market fund $ 10,118 $ — $ — $ 10,118 Forward contracts — 8 — 8 Total financial assets $ 10,118 $ 8 $ — $ 10,126 Contingent consideration liability (1) $ — $ — $ 2,867 $ 2,867 Total financial liabilities $ — $ — $ 2,867 $ 2,867 (1) The significant unobservable inputs used in the fair value measurement of the contingent consideration classified as Level 3 above are the achievement of booking targets and the discount rate. The following table represents the fair value hierarchy of the Company’s financial assets and financial liabilities measured at fair value as of December 31, 2015 : Level 1 Level 2 Level 3 Total (In thousands) Money market fund $ 10,114 $ — $ — $ 10,114 Forward contracts — 32 — 32 Total financial assets $ 10,114 $ 32 $ — $ 10,146 Contingent consideration liability (1) $ — $ — $ 5,823 $ 5,823 Total financial liabilities $ — $ — $ 5,823 $ 5,823 (1) The significant unobservable inputs used in the fair value measurement of the contingent consideration classified as Level 3 above are the achievement of booking targets and the discount rate. Net investment in sales-type leases. The carrying amount of the Company's sales-type lease receivables is a reasonable estimate of fair value as the unearned interest income is immaterial. Foreign Currency Risk Management The Company operates in foreign countries, which exposes it to market risk associated with foreign currency exchange rate fluctuations between the U.S. dollar and various foreign currencies, the most significant of which is the British Pound and Euro. In order to manage foreign currency risk, the Company enters into foreign exchange forward contracts to mitigate risks associated with changes in spot exchange rates of mainly non-functional currency denominated assets or liabilities of its foreign subsidiaries. In general, the market risk related to these contracts is offset by corresponding gains and losses on the hedged transactions. By working only with major banks and closely monitoring current market conditions, the Company seeks to limit the risk that counterparties to these contracts may be unable to perform. The foreign exchange forward contracts are measured at fair value and reported as other current assets or accrued liabilities on the Condensed Consolidated Balance Sheets. The derivative instruments the Company uses to hedge this exposure are not designated as hedges. Any gains or losses on the foreign exchange forward contracts are recognized in earnings as Other Income/Expense in the period incurred in the Condensed Consolidated Statements of Operations. The Company does not enter into derivative contracts for trading purposes. The aggregate notional amounts of the Company's outstanding foreign exchange contracts as of March 31, 2016 and December 31, 2015 were $0.3 million and $0.4 million , respectively. The aggregate fair values of these outstanding foreign exchange contracts as of March 31, 2016 and December 31, 2015 were less than $0.1 million .

Balance Sheet Components

Balance Sheet Components	3 Months Ended
	Mar. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	Balance Sheet Components March 31, December 31, (In thousands) Inventories: Raw materials $ 17,623 $ 11,582 Work in process 7,062 1,653 Finished goods 47,229 33,359 Total inventories $ 71,914 $ 46,594 Property and equipment: Equipment $ 68,335 $ 43,533 Furniture and fixtures 8,314 5,897 Leasehold improvements 14,955 9,063 Software 35,399 30,693 Construction in progress 5,408 3,651 Property and equipment, gross 132,411 92,837 Accumulated depreciation and amortization (90,203 ) (60,528 ) Total property and equipment, net $ 42,208 $ 32,309 Other long term assets: Capitalized software, net $ 27,130 $ 26,011 Other assets 1,679 1,883 Total other long term assets, net $ 28,809 $ 27,894 Accrued liabilities: Advance payments from customers $ 7,443 $ 8,327 Rebates and lease buyouts 4,384 4,702 Group purchasing organization fees 2,493 2,983 Taxes payable 2,722 2,768 Other accrued liabilities 17,861 11,353 Total accrued liabilities $ 34,903 $ 30,133

Investment in Sales-Type Leases

Investment in Sales-Type Leases, Net	3 Months Ended
	Mar. 31, 2016
Leases [Abstract]
Investment in Sales-Type Leases, Net	Investment in Sales-Type Leases, Net On recurring basis, we enter into sales-type lease transactions which vary in length from one to five years. The receivables as a result of these types of transactions are collateralized by the underlying equipment leased and consist of the following components at March 31, 2016 and December 31, 2015 : March 31, December 31, (In thousands) Minimum lease payments to be received, net $ 32,541 $ 22,255 Less: Unearned interest income portion (2,470 ) (1,014 ) Investment in sales-type leases, net 30,071 21,241 Less: Short-term investment in sales-type leases, net (1) (9,034 ) (6,757 ) Long-term investment in sales-type leases, net $ 21,037 $ 14,484 (1) The short-term portion of the net investments in sales-type leases are included in the Other current assets on the Condensed Consolidated Balance Sheets. The Company evaluates its sales-type leases individually and collectively for impairment. The allowance for credit losses were $0.3 million and $0.2 million as of March 31, 2016 and of December 31, 2015 , respectively. At March 31, 2016 , the future minimum lease payments under sales-type leases are as follows: March 31, (In thousands) Remaining nine months of 2016 $ 7,253 2017 9,126 2018 7,328 2019 5,032 2020 3,200 Thereafter 602 Total $ 32,541

Goodwill and Intangible Assets

Goodwill and Intangible Assets	3 Months Ended
	Mar. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill The following table represents changes in the carrying amount of goodwill: Automation and Analytics Medication Adherence Total (In thousands) Net balance as of December 31, 2015 $ 54,316 $ 93,590 $ 147,906 Goodwill acquired 164,824 164,824 Foreign currency exchange rate fluctuations 77 (296 ) (219 ) Net balance as of March 31, 2016 $ 219,217 $ 93,294 $ 312,511 Intangible assets, net The carrying amounts of intangibles assets as of March 31, 2016 and December 31, 2015 are as follows: March 31, 2016 Gross carrying amount Accumulated amortization Foreign currency exchange rate fluctuations Net carrying amount Useful life (years) (In thousands, except for years) Customer relationships $ 126,338 $ (11,656 ) $ (818 ) $ 113,864 5 - 30 Acquired technology 70,041 (7,850 ) 173 62,364 3 - 20 In-process Technology 3,900 — — 3,900 - Trade names 8,542 (2,672 ) 36 5,906 1 - 12 Patents 2,042 (407 ) — 1,635 2 - 20 Backlog 20,615 (3,653 ) (20 ) 16,942 1 - 3 Non-compete agreements 1,800 (150 ) 1,650 3 Total intangibles assets, net $ 233,278 $ (26,388 ) $ (629 ) $ 206,261 December 31, 2015 Gross carrying amount Accumulated amortization Foreign currency exchange rate fluctuations Net carrying amount Useful life (years) (In thousands, except for years) Customer relationships $ 69,554 $ (11,315 ) $ (719 ) $ 57,520 5 - 30 Acquired technology 30,870 (6,088 ) 59 24,841 3 - 20 Trade names 8,052 (2,551 ) (14 ) 5,487 1 - 12 Patents 1,960 (384 ) — 1,576 2 - 20 Backlog 415 (163 ) (11 ) 241 2 Total intangibles assets, net $ 110,851 $ (20,501 ) $ (685 ) $ 89,665 Amortization expense of intangible assets was $9.2 million and $1.3 million for the three months ended March 31, 2016 and March 31, 2015 , respectively. The estimated future amortization expenses for amortizable intangible assets are as follows: March 31, (In thousands) Remaining nine months of 2016 $ 27,031 2017 22,834 2018 21,221 2019 16,143 2020 15,138 Thereafter 99,994 Total $ 202,361

Debt

Debt	3 Months Ended
	Mar. 31, 2016
Debt Disclosure [Abstract]
Debt	Debt On January 5, 2016 , the Company entered into a $400 million senior secured credit facility pursuant to a credit agreement, by and among the Company, the lenders from time to time party thereto, Wells Fargo Securities, LLC, as Sole Lead Arranger and Wells Fargo Bank, National Association, as administrative agent (the “Credit Agreement”). The Credit Agreement provides for (a) a five -year revolving credit facility of $200 million (the “Revolving Credit Facility”) and (b) a five -year $200 million term loan facility (the “Term Loan Facility” and together with the Revolving Credit Facility, the “Facilities”). In addition, the Credit Agreement includes a letter of credit sub-limit of up to $10 million and a swing line loan sub-limit of up to $10 million . The Credit Agreement expires on January 5, 2021, upon which date all remaining outstanding borrowings are due and payable. Loans under the Facilities bear interest, at the Company’s option, at a rate equal to either (a) the LIBOR Rate, plus an applicable margin ranging from 1.50% to 2.25% per annum based on the Company’s Consolidated Total Net Leverage Ratio (as defined in the Credit Agreement), or (b) an alternate base rate equal to the highest of (i) the prime rate, (ii) the federal funds rate plus 0.50% , and (iii) LIBOR for an interest period of one month, plus an applicable margin ranging from 0.50% to 1.25% per annum based on the Company’s Consolidated Total Net Leverage Ratio (as defined in the 2016 Credit Agreement). Undrawn commitments under the Revolving Credit Facility will be subject to a commitment fee ranging from 0.20% to 0.35% per annum based on the Company’s Consolidated Total Net Leverage Ratio on the average daily unused portion of the Revolving Credit Facility. A letter of credit participation fee ranging from 1.50% to 2.25% per annum based on the Company’s Consolidated Total Net Leverage Ratio will accrue on the average daily amount of letter of credit exposure. The Company is permitted to make voluntary prepayments at any time without payment of a premium or penalty, except for any amounts relating to the LIBOR breakage indemnity described in the Credit Agreement. The Company is required to make mandatory prepayments under the Term Loan Facility with (a) net cash proceeds from any issuances of debt (other than certain permitted debt) and (b) net cash proceeds from certain asset dispositions (other than certain asset dispositions) and insurance and condemnation events (subject to reinvestment rights and certain other exceptions). Loans under the Term Loan Facility will amortize in quarterly installments, equal to 5% per annum of the original principal amount thereof during the first two years, which shall increase to 10% per annum during the third and fourth years, and 15% per annum during the fifth year, with the remaining balance payable on January 5, 2021. The Company is required to make mandatory prepayments under the Revolving Credit Facility if at any time the aggregate outstanding principal amount of loans together with the total amount of outstanding letters of credit exceeds the aggregate commitments, with such mandatory prepayment to be equal to the amount of such excess. The Credit Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the Company and its subsidiaries, including, among other things, restrictions on indebtedness, liens, investments, mergers, dispositions, dividends and other distributions. The Credit Agreement contains financial covenants that require the Company and its subsidiaries to not exceed a maximum consolidated total leverage ratio and maintain a minimum fixed charge coverage ratio. The Company’s obligations under the Credit Agreement and any swap obligations and banking services obligations owing to a lender (or an affiliate of a lender) are guaranteed by certain of its domestic subsidiaries and secured by substantially all of its and the subsidiary guarantors’ assets. In connection with entering into the Credit Agreement, and as a condition precedent to borrowing loans thereunder, the Company and certain of the Company’s other direct and indirect subsidiaries have entered into certain ancillary agreements, including, but not limited to, a collateral agreement and subsidiary guaranty agreement. The Company was in full compliance with all covenants as of March 31, 2016. On January 5, 2016, the Company borrowed the full $200 million under the Term Loan Facility and $55 million under the Revolving Credit Facility to complete the Aesynt acquisition and pay related fees and expenses. In connection with these Facilities, the Company incurred $7.9 million of debt issuance costs. The debt issuance costs were capitalized and presented as a direct deduction from the carrying amount of that debt liability in accordance with the accounting guidance. The debt issuance costs are being amortized to interest expense using the straight line method from issuance date through 2021. The components of the Company’s debt obligations as of March 31, 2016 and December 31, 2015 are as follows: December 31, 2015 Additions Repayment/amortization March 31, 2016 (In thousands) Term loan facility $ — $ 200,000 $ — $ 200,000 Revolving credit facility — 55,000 (20,000 ) 35,000 Total debt under the facilities (1) — 255,000 (20,000 ) 235,000 Less: Deferred issuance cost (7,949 ) 397 (7,552 ) Total Debt, net of deferred issuance cost $ — $ 247,051 $ (19,603 ) 227,448 Long term debt, current portion, net of deferred issuance cost 8,410 Long term debt, net of deferred issuance cost $ 219,038 (1) The fair value of total debt under the facilities approximates the book value as of March 31, 2016.

Deferred revenue

Deferred revenue	3 Months Ended
	Mar. 31, 2016
Revenue Recognition [Abstract]
Deferred revenue	Deferred revenue The Short-term deferred revenue includes deferred revenue from product sales and service contracts, net of deferred cost of sales of $19.0 million and $15.7 million as of March 31, 2016 and December 31, 2015, respectively. The short-term deferred revenues from product sales relate to the delivered and invoiced products, pending installation and acceptance, expected to occur within the next twelve months. The Long-term deferred revenue includes deferred revenue from the service contracts of $17.8 million and $18.0 million , as of March 31, 2016 and December 31, 2015, respectively.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Lease commitments The Company leases office space and office equipment under operating leases. Commitments under operating leases primarily relate to leasehold property and office equipment. At March 31, 2016 , the minimum future payments on non-cancelable operating leases were as follows: (In thousands) Remaining nine months of 2016 $ 7,996 2017 10,441 2018 9,921 2019 9,802 2020 6,256 Thereafter 10,870 Total minimum future lease payments $ 55,286 Purchase obligations During the course of the business, the Company issues purchase orders based on its current manufacturing needs. At March 31, 2016 , the Company had non-cancelable purchase commitments of $38.9 million , which are expected to be paid within the next twelve months. Legal Proceedings The Company is currently involved in various legal proceedings. As required under ASC 450, Contingencies , the Company accrues for contingencies when it believes that a loss is probable and that it can reasonably estimate the amount of any such loss. The Company has not recorded any accrual for contingent liabilities associated with the legal proceedings described below based on its belief that any potential loss, while reasonably possible, is not probable. Further, any possible range of loss in these matters cannot be reasonably estimated at this time. The Company believes that it has valid defenses with respect to legal proceedings pending against it. However, litigation is inherently unpredictable, and it is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of this contingency or because of the diversion of management's attention and the creation of significant expenses. The Company’s pending legal proceeding as of March 31, 2016 was as follows: On September 12, 2014, MV Circuit Design, Inc., an Ohio company ("MV Circuit"), brought an action to correct the inventorship of certain patents owned by the Company, as well as related state-law claims against the Company in the Northern District of Ohio (Case No. 1:14-cv-02028-DAP) regarding allegations of fraud in the filing and prosecution of U.S. Patent Nos. 8,180,485, 8,773,270, 8,812,153, PCT/US2007/003765, PCT/US2011/063597, and PCT/US2011/0635505 (the “Action”). On November 14, 2014, the Company filed a Motion to Dismiss the Action. MV Circuit responded on January 29, 2015, and the Company replied in support of its Motion to Dismiss on February 17, 2015. On March 24, 2015, the Court issued an Order granting in part and denying in part the Motion to Dismiss. Specifically, the Court granted the Company's Motion to Dismiss with respect to Counts 4, 5, and 6 (declaratory judgments regarding PCT/US2007/003765, PCT/US2011/063597, and PCT/US2011/0635505) and count 13 (civil conspiracy). The Court denied the Company's Motion to Dismiss with respect to Count 9 (fraud), Count 7 (fraudulent concealment) and Count 8 (negligent misrepresentation). The Company filed an Answer to the Complaint on April 8, 2015. Following an initial Case Management Conference on April 22, 2015, the Court ordered MV Circuit and the Company to make a limited initial production of documents. The parties completed this initial document production and have held further conference calls with the Court to report on their settlement negotiations. During a conference call held on February 11, 2016, the Court set a deadline of March 14, 2016 for the parties to either file notification of settlement or a proposed litigation schedule. The parties have requested three extensions of the March 14th deadline, with the current deadline requested for June 10, 2016.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2016
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes We provide for income taxes for each interim period based on the estimated annual effective tax rate for the year, adjusting for discrete items in the quarter in which they arise. The annual effective tax rate before discrete items was 37.0% and 38.6% for the three months ended March 31, 2016 and 2015, respectively. The 2016 annual effective tax rate differed from the statutory rate of 35% primarily due to the unfavorable impact of state income taxes, non-deductible equity charges, and other non-deductible expenditures, which were partially offset by the domestic production activities deduction and the Federal Research & Development credit, which was permanently reinstated on December 18, 2015. The 2015 annual effective tax rate differed from the statutory rate of 35% primarily due to the unfavorable impact of state income taxes, non-deductible equity charges, and other non-deductible expenditures, which were partially offset by the domestic production activities deduction. As of March 31, 2016 and December 31, 2015, the Company had gross unrecognized tax benefits of $9.9 million and $7.2 million , respectively. It is the Company’s policy to classify accrued interest and penalties as part of the unrecognized tax benefits, but to record interest and penalties in operating expense. As of March 31, 2016 and December 31, 2015, the amount of accrued interest and penalties was $1.0 million and $0.2 million , respectively. As of March 31, 2016, calendar years 2011 and thereafter are open and subject to potential examination in one or more jurisdictions. However, because all of the net operating loss and research credit carryforwards that may be used in future years are subject to adjustment, if and when utilized, our federal and California tax years remain open from 1996 and 1992, respectively. The Company is currently under examination by the Internal Revenue Service for the 2011 through 2013 tax years. Although the Company believes it has adequately provided for uncertain tax positions, the provisions on these positions may change as revised estimates are made or the underlying matters are settled or otherwise resolved. It is not possible at this time to reasonably estimate changes in the unrecognized tax benefits within the next twelve months.

Employee Benefits and Share-Bas

Employee Benefits and Share-Based Compensation	3 Months Ended
	Mar. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Employee Benefits and Share-Based Compensation	Employee Benefits and Share-Based Compensation Stock based plans For a detailed explanation of the Company's stock plans and subsequent changes, please refer to Note 11, Employee Benefits and Stock-Based Compensation, of its Annual Report on Form 10-K for the year ended December 31, 2015, filed with the SEC on February 26, 2016. Share-based compensation expense The following table sets forth the total share-based compensation expense recognized in the Company's Condensed Consolidated Statements of Operations: Three months ended March 31, March 31, (In thousands) Cost of product and service revenues $ 549 $ 517 Research and development 641 434 Selling, general and administrative 2,701 2,714 Total share-based compensation expense $ 3,891 $ 3,665 The following weighted average assumptions are used to value stock options and Employee Stock Purchase Plan ("ESPP") shares issued pursuant to the Company's equity incentive plans for the three months ended March 31, 2016 and March 31, 2015 : Three months ended March 31, March 31, (In thousands, except percentages) Stock Option Plans Expected life, years 4.92 5.04 Expected volatility, % 32.6 % 33.2 % Risk free interest rate, % 1.40 % 1.66 % Estimated forfeiture rate % 8.6 % 2.5 % Dividend yield, % — % — % Three months ended March 31, March 31, (In thousands, except percentages) Employee Stock Purchase Plan Expected life, years 0.5-2.0 0.5-2.0 Expected volatility, % 25.79-34.79% 28.52-37.53% Risk free interest rate, % 0.26-0.79% 0.03-0.53% Dividend yield, % — % — % Stock options activity A summary of the stock options activity under the 2009 Plan is presented below: Number of Shares Weighted-Average Exercise Price Weighted-Average Remaining Years Aggregate Intrinsic Value (1) (In thousands, except per share data) Stock Options Outstanding at December 31, 2015 2,688 $ 22.89 6.9 Granted 376 27.75 Exercised (49 ) 13.48 Expired (1 ) 19.96 Forfeited (38 ) 28.51 Outstanding at March 31, 2016 2,976 $ 23.59 7.0 $ 15,891 Exercisable at March 31, 2016 1,478 $ 18.53 5.0 $ 14,329 Vested and expected to vest at March 31, 2016 and thereafter 2,790 $ 23.23 6.9 $ 15,806 _________________________________________________ The weighted-average fair value per share of options granted during the three months ended March 31, 2016 , was $8.51 , and the weighted-average fair value per share of options granted during the months ended March 31, 2015 was $9.82 . The intrinsic value of options exercised during the three months ended March 31, 2016 and March 31, 2015 was $0.7 million and $2.4 million , respectively. As of March 31, 2016 , total unrecognized compensation cost related to unvested stock options was $11.3 million , which is expected to be recognized over a weighted-average vesting period of 3.1 years. Restricted stock activity Summaries of restricted stock activity under the 2009 Plan are presented below: Number of Shares Weighted-Average Grant Date Fair Value Weighted-Average Remaining Years Aggregate Intrinsic Value (In thousands, except per share data) Restricted Stock Units ("RSU") Outstanding at December 31, 2015 417 $ 28.49 1.6 Granted 90 27.77 Vested (23 ) 25.76 Forfeited (7 ) 28.42 Outstanding and unvested at March 31, 2016 477 $ 28.49 1.5 $ 13,292 Expected to vest after March 31, 2016 419 $ 28.39 1.4 $ 11,677 The weighted-average grant date fair value per share of RSU granted during the three months ended March 31, 2016 and March 31, 2015 was $27.77 and $33.97 , respectively. As of March 31, 2016 , total unrecognized compensation expense related to RSUs was $10.7 million , which is expected to be recognized over the remaining weighted-average vesting period of 2.8 years. Number of Shares Weighted-Average Grant Date Fair Value (In thousands, except per share data) Restricted Stock Awards ("RSA") Outstanding at December 31, 2015 31 $ 35.98 Granted — — Vested — — Forfeited — — Outstanding and unvested at March 31, 2016 31 $ 35.98 As of March 31, 2016 , total unrecognized compensation cost related to RSAs was $0.1 million , which is expected to be recognized over the remaining weighted-average vesting period of 0.2 years . Performance-based restricted stock unit activity A summary of the performance-based restricted stock activity under the Plan is presented below: Number of Shares Weighted-Average Grant Date Fair Value Per Unit (In thousands, except per share data) Performance-based Restricted Stock Units ("PSU") Outstanding at December 31, 2015 151 $ 23.33 Granted 123 24.66 Vested (15 ) 29.56 Forfeited — — Outstanding and unvested at March 31, 2016 259 $ 23.60 The weighted-average grant date fair value per share of PSUs granted during the three months ended March 31, 2016 and March 31, 2015 was $24.66 and $29.56 , respectively. As of March 31, 2016 , total unrecognized compensation cost related to PSUs was approximately $3.2 million , which is expected to be recognized over the remaining weighted-average period of 1.5 years . Employee Stock Purchase Plan activity As of March 31, 2016 , the unrecognized compensation cost related to the shares to be purchased under the ESPP was approximately $7.1 million and is expected to be recognized over a weighted-average period of two years. Summary of shares reserved for future issuance under equity incentive plans The Company had the following ordinary shares reserved for future issuance under its equity incentive plans as of March 31, 2016 : Number of Shares (In thousands) Share options outstanding 2,976 Non-vested restricted share awards 767 Shares authorized for future issuance 3,017 ESPP shares available for future issuance 3,053 Total shares reserved for future issuance 9,813 During the three month period ended March 31 2016 and March 31, 2015, the Company did not repurchase any common stock outstanding.

Segment Information

Segment Information	3 Months Ended
	Mar. 31, 2016
Segment Reporting [Abstract]
Segment Information	Segment Information The Company's Chief Operating Decision Maker ("CODM") is its Chief Executive Officer. The CODM allocates resources and evaluates the performance of the Company's segments using information about its revenues, gross profit, and income from operations. Such evaluation excludes general corporate-level costs that are not specific to either of the reportable segments and are managed separately at the corporate level. Corporate-level costs include expenses related to executive management, finance and accounting, human resources, legal, training and development, and certain administrative expenses. The two operating segments, which are the same as the Company's two reportable segments, are as follows: Automation and Analytics The Automation and Analytics segment is organized around the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Automation and Analytics products are designed to enable the Company's customers to enhance and improve the effectiveness of the medication-use process, the efficiency of the medical-surgical supply chain, overall patient care and clinical and financial outcomes of medical facilities. Through modular configuration and upgrades, the Company's systems can be tailored to specific customer needs. The financial results of Aesynt acquired in the first quarter of 2016 are included in the Automation and Analytics segment. Medication Adherence The Medication Adherence segment includes primarily the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services. These products are used to manage medication administration outside of the hospital setting and include medication adherence products sold under the brand names MTS Medication Technologies ("MTS"), Surgichem Limited ("Surgichem"), and under the Omnicell and SureMed brands. MTS products consist of proprietary medication packaging systems and related products for use by institutional pharmacies servicing long-term care, and correctional facilities or retail pharmacies serving patients in their local communities. The following table summarizes the financial performance of the Company's reportable segments, including a reconciliation of income from segment operations to income from total operations: Three months ended March 31, 2016 March 31, 2015 Automation and Analytics Medication Adherence Total Automation and Analytics Medication Adherence Total (In thousands) Revenues $ 148,945 $ 22,059 $ 171,004 $ 92,779 $ 23,442 $ 116,221 Cost of revenues 77,207 13,852 91,059 38,852 15,684 54,536 Gross profit 71,738 8,207 79,945 53,927 7,758 61,685 Operating expenses 52,205 5,611 57,816 28,589 6,341 34,930 Income from segment operations $ 19,533 $ 2,596 $ 22,129 $ 25,338 $ 1,417 $ 26,755 Corporate costs 20,277 16,376 Income from operations $ 1,852 $ 10,379 ________________________________________________ Significant customers There were no customers that accounted for more than 10% of our total revenues for the three months ended March 31, 2016 and March 31, 2015 . Geographical Information Revenues Three months ended March 31, March 31, (In thousands) United States $ 143,493 $ 97,823 Rest of world (1) 27,511 18,398 Total revenues $ 171,004 $ 116,221 (1) No individual country represented more than 10% of the respective totals. Property and equipment, net March 31, December 31, (In thousands) United States $ 38,880 $ 29,506 Rest of world (1) 3,328 2,803 Total property and equipment, net $ 42,208 $ 32,309 _________________________________________________ (1) No individual country represented more than 10% of the respective totals. Property and equipment, net is attributed to the geographic location in which it is located.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2016
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events During the second quarter of 2016, the Company integrated its Sales and Field teams in North America to better serve its customers which resulted in a reduction in headcount of 34 employees. Accordingly, the Company will accrue approximately $1.5 million of restructuring charges in the second quarter ending June 30, 2016, based on agreements with terminated employees covering salary and benefit continuation.

Organization and Summary of S21

Organization and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2016
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation The accompanying unaudited Condensed Consolidated Financial Statements reflect, in the opinion of management, all adjustments, consisting of normal recurring adjustments and accruals, necessary to present fairly the financial position of the Company as of March 31, 2016 and December 31, 2015 , the results of their operations, comprehensive income (loss) and cash flows for the three months ended March 31, 2016 and March 31, 2015 . Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and accompanying Notes included in the Company's annual report on Form 10-K for the year ended December 31, 2015 filed with the SEC on February 26, 2016. The Company's results of operations, comprehensive income (loss) and cash flows for the three months ended March 31, 2016 are not necessarily indicative of results that may be expected for the year ending December 31, 2016 , or for any future period.
Principles of consolidation	Principles of consolidation The Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Use of estimates	Use of estimates The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company's Condensed Consolidated Financial Statements and accompanying Notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management's best knowledge of current events and actions that may impact the Company in the future, actual results may be different from the estimates. The Company's critical accounting policies are those that affect its financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, share-based compensation, inventory valuation, accounts receivable and notes receivable (investment in sales-type leases), capitalized software development costs, valuation of goodwill and purchased intangibles and long-lived assets, fair value of assets acquired and liabilities assumed in business combinations, and accounting for income taxes.
Segment reporting change	Segment reporting change The Company's Chief Operating Decision Maker ("CODM") is its Chief Executive Officer. The CODM allocates resources and evaluates the performance of the Company's segments using information about its revenues, gross profit, and income from operations. Such evaluation excludes general corporate-level costs that are not specific to either of the reportable segments and are managed separately at the corporate level. Corporate-level costs include expenses related to executive management, finance and accounting, human resources, legal, training and development, and certain administrative expenses. The operating results of the recently acquired Aesynt business is included in the Company's Automation and Analytics reporting segment.
Concentration of credit risk	Concentration of credit risk Financial instruments that may potentially subject the Company to concentrations of credit risk consist principally of cash equivalents and accounts receivable. Cash equivalents are maintained with several financial institutions and may exceed the amount of insurance provided on such balances. The majority of the Company's accounts receivable are derived from sales to customers for commercial applications. The Company performs ongoing credit evaluations of its customers’ financial condition and limit the amount of credit extended when deemed necessary but generally require no collateral. The Company maintains reserves for potential credit losses. The Company's products are broadly distributed and there were no customers that accounted for more than 10% of its accounts receivable as of March 31, 2016 and December 31, 2015 . The Company believes that it has no significant concentrations of credit risk as of March 31, 2016 .
Recently issued authoritative guidance	Recently issued authoritative guidance In March 2016, the FASB issued ASU No. 2016-09, Compensation—Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. This ASU simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. The provision of ASU No. 2016-09 are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted for any entity in any interim or annual period. If an entity early adopts the amendments in an interim period, any adjustments are reflected as of the beginning of the fiscal year that includes that interim period. An entity that elects early adoption must adopt all of the amendments in the same period. The Company is currently in the process of evaluating the impact of the adoption of ASU 2016-09 on its consolidated financial statements. There was no other recently issued authoritative guidance that has a material impact on our Condensed Consolidated Financial Statements through the reporting date.

Business Acquisitions (Tables)

Business Acquisitions (Tables)	3 Months Ended
	Mar. 31, 2016
Business Acquisition [Line Items]
Business Acquisition, Pro Forma Information	The pro forma adjustments include the impact of fair value adjustment related to deferred revenue, inventory fair value adjustment, amortization of intangible assets, stock-based compensation expense, interest expense and amortization of deferred issuance cost, and certain classification to conform to Omnicell's accounting policies. Three months ended March 31, 2016 2015 (In thousands, except per share data) Pro forma net revenues $ 171,004 $ 159,614 Pro forma net income (loss) $ (378 ) $ (119 ) Pro forma net income per share basic $ (0.01 ) $ 0.00 Pro forma net income per share diluted $ (0.01 ) $ 0.00
Avantec
Business Acquisition [Line Items]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed and Weighted Average Useful Life	Mach4 Avantec Total (In thousands) Cash $ 397 $ 3,392 $ 3,789 Accounts receivable 3,743 3,607 7,350 Inventory 3,580 1,428 5,008 Deferred tax assets and other current assets 368 89 457 Total current assets 8,088 8,516 16,604 Property and equipment 463 — 463 Intangibles 7,710 6,341 14,051 Goodwill 10,591 15,606 26,197 Other non-current assets 52 — 52 Total assets 26,904 30,463 57,367 Current liabilities 3,684 4,125 7,809 Non-current deferred tax liabilities 2,564 1,269 3,833 Deferred service revenue and gross profit 2,314 928 3,242 Other non-current liabilities 1,056 — 1,056 Total purchase price 17,286 24,141 41,427 Total purchase price, net of cash received $ 16,889 $ 20,749 $ 37,638 Intangible assets acquired and their respective estimated remaining useful lives over which each asset will be amortized are as follows: Mach4 Avantec Fair value Weighted Fair value Weighted average useful life (In thousands) (In years) (In thousands) (In years) Developed technology $ 3,290 8 $ — — Trade name 850 6 92 2 Customer relationships 3,570 10 5,834 12 Backlog — — 415 2 Total purchased intangible assets $ 7,710 $ 6,341
Aesynt Holding, L.P., Aesynt, Ltd.
Business Acquisition [Line Items]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed and Weighted Average Useful Life	The following table represents the preliminary estimated allocation of the purchase price to the assets acquired and the liabilities assumed by the Company, reconciled to the purchase price transferred included in the Company's Condensed Consolidated Balance Sheet: (In thousands) Cash $ 8,164 Accounts receivable 44,895 Inventory 20,111 Other current assets 4,381 Total current assets 77,551 Property and equipment 10,389 Intangible assets 123,700 Goodwill 164,824 Other non-current assets 968 Total assets 377,432 Current liabilities 25,821 Deferred revenue, net 25,631 Non-current deferred tax liabilities 43,927 Other non-current liabilities 2,431 Total liabilities 97,810 Total purchase price 279,622 Total purchase price, net of cash received $ 271,458 Identifiable intangible assets (preliminary) acquired and their respective estimated remaining useful lives over which each asset will be amortized areas are as follows: Fair value Weighted (In thousands) (In years) Customer relationships $ 58,200 14-16 Developed technology 38,800 8 Backlog 20,200 1-3 In-process R&D (1) 3,900 - Non-compete 1,800 3 Trade names 800 1 Total purchased intangible assets $ 123,700

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	3 Months Ended
	Mar. 31, 2016
Earnings Per Share [Abstract]
Basic and Diluted Net Income Per Share	The calculation of basic and diluted net income (loss) per share is as follows: Three months ended March 31, 2016 2015 (In thousands, except per share data) Net income (loss) $ (378 ) $ 6,318 Weighted-average shares outstanding — basic 35,740 36,024 Effect of dilutive securities from stock award plans — 890 Weighted-average shares outstanding — diluted $ 35,740 $ 36,914 Net income (loss) per share — basic $ (0.01 ) $ 0.18 Net income (loss) per share — diluted $ (0.01 ) $ 0.17 Anti-dilutive weighted-average shares related to stock award plans 2,045 484

Cash and Cash Equivalents and24

Cash and Cash Equivalents and Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2016
Fair Value Disclosures [Abstract]
Assets Measured at Fair Value On A Recurring Basis	The cash and cash equivalents at March 31, 2016 and December 31, 2015 were as follows: March 31, December 31, 2015 (In thousands) Cash $ 43,369 $ 72,103 Money market fund 10,118 10,114 Total cash and cash equivalents $ 53,487 $ 82,217
Schedule of Financial Assets Measured At Fair Value	The following table represents the fair value hierarchy of the Company’s financial assets and financial liabilities measured at fair value as of March 31, 2016 : Level 1 Level 2 Level 3 Total (In thousands) Money market fund $ 10,118 $ — $ — $ 10,118 Forward contracts — 8 — 8 Total financial assets $ 10,118 $ 8 $ — $ 10,126 Contingent consideration liability (1) $ — $ — $ 2,867 $ 2,867 Total financial liabilities $ — $ — $ 2,867 $ 2,867 (1) The significant unobservable inputs used in the fair value measurement of the contingent consideration classified as Level 3 above are the achievement of booking targets and the discount rate. The following table represents the fair value hierarchy of the Company’s financial assets and financial liabilities measured at fair value as of December 31, 2015 : Level 1 Level 2 Level 3 Total (In thousands) Money market fund $ 10,114 $ — $ — $ 10,114 Forward contracts — 32 — 32 Total financial assets $ 10,114 $ 32 $ — $ 10,146 Contingent consideration liability (1) $ — $ — $ 5,823 $ 5,823 Total financial liabilities $ — $ — $ 5,823 $ 5,823 (1) The significant unobservable inputs used in the fair value measurement of the contingent consideration classified as Level 3 above are the achievement of booking targets and the discount rate.

Balance Sheet Components (Table

Balance Sheet Components (Tables)	3 Months Ended
	Mar. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Balance Sheet	March 31, December 31, (In thousands) Inventories: Raw materials $ 17,623 $ 11,582 Work in process 7,062 1,653 Finished goods 47,229 33,359 Total inventories $ 71,914 $ 46,594 Property and equipment: Equipment $ 68,335 $ 43,533 Furniture and fixtures 8,314 5,897 Leasehold improvements 14,955 9,063 Software 35,399 30,693 Construction in progress 5,408 3,651 Property and equipment, gross 132,411 92,837 Accumulated depreciation and amortization (90,203 ) (60,528 ) Total property and equipment, net $ 42,208 $ 32,309 Other long term assets: Capitalized software, net $ 27,130 $ 26,011 Other assets 1,679 1,883 Total other long term assets, net $ 28,809 $ 27,894 Accrued liabilities: Advance payments from customers $ 7,443 $ 8,327 Rebates and lease buyouts 4,384 4,702 Group purchasing organization fees 2,493 2,983 Taxes payable 2,722 2,768 Other accrued liabilities 17,861 11,353 Total accrued liabilities $ 34,903 $ 30,133

Investment in Sales-Type Leas26

Investment in Sales-Type Leases, Net (Tables)	3 Months Ended
	Mar. 31, 2016
Leases [Abstract]
Schedule of Long Term Net Investment in Sale-Type Leases	The receivables as a result of these types of transactions are collateralized by the underlying equipment leased and consist of the following components at March 31, 2016 and December 31, 2015 : March 31, December 31, (In thousands) Minimum lease payments to be received, net $ 32,541 $ 22,255 Less: Unearned interest income portion (2,470 ) (1,014 ) Investment in sales-type leases, net 30,071 21,241 Less: Short-term investment in sales-type leases, net (1) (9,034 ) (6,757 ) Long-term investment in sales-type leases, net $ 21,037 $ 14,484 (1) The short-term portion of the net investments in sales-type leases are included in the Other current assets on the Condensed Consolidated Balance Sheets.
Schedule of Net Sale-Type Leases Minimum Lease Receivables	At March 31, 2016 , the future minimum lease payments under sales-type leases are as follows: March 31, (In thousands) Remaining nine months of 2016 $ 7,253 2017 9,126 2018 7,328 2019 5,032 2020 3,200 Thereafter 602 Total $ 32,541

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Carrying Amount of Goodwill	The following table represents changes in the carrying amount of goodwill: Automation and Analytics Medication Adherence Total (In thousands) Net balance as of December 31, 2015 $ 54,316 $ 93,590 $ 147,906 Goodwill acquired 164,824 164,824 Foreign currency exchange rate fluctuations 77 (296 ) (219 ) Net balance as of March 31, 2016 $ 219,217 $ 93,294 $ 312,511
Intangible Assets, Net	The carrying amounts of intangibles assets as of March 31, 2016 and December 31, 2015 are as follows: March 31, 2016 Gross carrying amount Accumulated amortization Foreign currency exchange rate fluctuations Net carrying amount Useful life (years) (In thousands, except for years) Customer relationships $ 126,338 $ (11,656 ) $ (818 ) $ 113,864 5 - 30 Acquired technology 70,041 (7,850 ) 173 62,364 3 - 20 In-process Technology 3,900 — — 3,900 - Trade names 8,542 (2,672 ) 36 5,906 1 - 12 Patents 2,042 (407 ) — 1,635 2 - 20 Backlog 20,615 (3,653 ) (20 ) 16,942 1 - 3 Non-compete agreements 1,800 (150 ) 1,650 3 Total intangibles assets, net $ 233,278 $ (26,388 ) $ (629 ) $ 206,261 December 31, 2015 Gross carrying amount Accumulated amortization Foreign currency exchange rate fluctuations Net carrying amount Useful life (years) (In thousands, except for years) Customer relationships $ 69,554 $ (11,315 ) $ (719 ) $ 57,520 5 - 30 Acquired technology 30,870 (6,088 ) 59 24,841 3 - 20 Trade names 8,052 (2,551 ) (14 ) 5,487 1 - 12 Patents 1,960 (384 ) — 1,576 2 - 20 Backlog 415 (163 ) (11 ) 241 2 Total intangibles assets, net $ 110,851 $ (20,501 ) $ (685 ) $ 89,665
Future Amortization Expense for Intangible Assets	The estimated future amortization expenses for amortizable intangible assets are as follows: March 31, (In thousands) Remaining nine months of 2016 $ 27,031 2017 22,834 2018 21,221 2019 16,143 2020 15,138 Thereafter 99,994 Total $ 202,361

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2016
Debt Disclosure [Abstract]
Schedule of Debt	The components of the Company’s debt obligations as of March 31, 2016 and December 31, 2015 are as follows: December 31, 2015 Additions Repayment/amortization March 31, 2016 (In thousands) Term loan facility $ — $ 200,000 $ — $ 200,000 Revolving credit facility — 55,000 (20,000 ) 35,000 Total debt under the facilities (1) — 255,000 (20,000 ) 235,000 Less: Deferred issuance cost (7,949 ) 397 (7,552 ) Total Debt, net of deferred issuance cost $ — $ 247,051 $ (19,603 ) 227,448 Long term debt, current portion, net of deferred issuance cost 8,410 Long term debt, net of deferred issuance cost $ 219,038 (1) The fair value of total debt under the facilities approximates the book value as of March 31, 2016.

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
Minimum Future Payments on Non-Cancelable Operating Leases	At March 31, 2016 , the minimum future payments on non-cancelable operating leases were as follows: (In thousands) Remaining nine months of 2016 $ 7,996 2017 10,441 2018 9,921 2019 9,802 2020 6,256 Thereafter 10,870 Total minimum future lease payments $ 55,286

Employee Benefits and Share-B30

Employee Benefits and Share-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-Based Compensation Expense Recognized in Consolidate Statements of Income	The following table sets forth the total share-based compensation expense recognized in the Company's Condensed Consolidated Statements of Operations: Three months ended March 31, March 31, (In thousands) Cost of product and service revenues $ 549 $ 517 Research and development 641 434 Selling, general and administrative 2,701 2,714 Total share-based compensation expense $ 3,891 $ 3,665
Estimate of Fair Value of Share-Based Awards, Employee Stock Purchase Plan	The following weighted average assumptions are used to value stock options and Employee Stock Purchase Plan ("ESPP") shares issued pursuant to the Company's equity incentive plans for the three months ended March 31, 2016 and March 31, 2015 : Three months ended March 31, March 31, (In thousands, except percentages) Stock Option Plans Expected life, years 4.92 5.04 Expected volatility, % 32.6 % 33.2 % Risk free interest rate, % 1.40 % 1.66 % Estimated forfeiture rate % 8.6 % 2.5 % Dividend yield, % — % — % Three months ended March 31, March 31, (In thousands, except percentages) Employee Stock Purchase Plan Expected life, years 0.5-2.0 0.5-2.0 Expected volatility, % 25.79-34.79% 28.52-37.53% Risk free interest rate, % 0.26-0.79% 0.03-0.53% Dividend yield, % — % — %
Estimate of Fair Value of Share-Based Awards, Share Options	The following weighted average assumptions are used to value stock options and Employee Stock Purchase Plan ("ESPP") shares issued pursuant to the Company's equity incentive plans for the three months ended March 31, 2016 and March 31, 2015 : Three months ended March 31, March 31, (In thousands, except percentages) Stock Option Plans Expected life, years 4.92 5.04 Expected volatility, % 32.6 % 33.2 % Risk free interest rate, % 1.40 % 1.66 % Estimated forfeiture rate % 8.6 % 2.5 % Dividend yield, % — % — % Three months ended March 31, March 31, (In thousands, except percentages) Employee Stock Purchase Plan Expected life, years 0.5-2.0 0.5-2.0 Expected volatility, % 25.79-34.79% 28.52-37.53% Risk free interest rate, % 0.26-0.79% 0.03-0.53% Dividend yield, % — % — %
Stock Option Activity under the Equity Incentive Plans	A summary of the stock options activity under the 2009 Plan is presented below: Number of Shares Weighted-Average Exercise Price Weighted-Average Remaining Years Aggregate Intrinsic Value (1) (In thousands, except per share data) Stock Options Outstanding at December 31, 2015 2,688 $ 22.89 6.9 Granted 376 27.75 Exercised (49 ) 13.48 Expired (1 ) 19.96 Forfeited (38 ) 28.51 Outstanding at March 31, 2016 2,976 $ 23.59 7.0 $ 15,891 Exercisable at March 31, 2016 1,478 $ 18.53 5.0 $ 14,329 Vested and expected to vest at March 31, 2016 and thereafter 2,790 $ 23.23 6.9 $ 15,806
Restricted Stock Units Activity under the Stock Option Activity under the Equity Incentive Plans	Summaries of restricted stock activity under the 2009 Plan are presented below: Number of Shares Weighted-Average Grant Date Fair Value Weighted-Average Remaining Years Aggregate Intrinsic Value (In thousands, except per share data) Restricted Stock Units ("RSU") Outstanding at December 31, 2015 417 $ 28.49 1.6 Granted 90 27.77 Vested (23 ) 25.76 Forfeited (7 ) 28.42 Outstanding and unvested at March 31, 2016 477 $ 28.49 1.5 $ 13,292 Expected to vest after March 31, 2016 419 $ 28.39 1.4 $ 11,677
Restricted Stock Units Award under the Stock Option Activity under the Equity Incentive Plans	Number of Shares Weighted-Average Grant Date Fair Value (In thousands, except per share data) Restricted Stock Awards ("RSA") Outstanding at December 31, 2015 31 $ 35.98 Granted — — Vested — — Forfeited — — Outstanding and unvested at March 31, 2016 31 $ 35.98
Performance Shares Restricted Stock Activity under the Stock Option Activity under the Equity Incentive Plans	A summary of the performance-based restricted stock activity under the Plan is presented below: Number of Shares Weighted-Average Grant Date Fair Value Per Unit (In thousands, except per share data) Performance-based Restricted Stock Units ("PSU") Outstanding at December 31, 2015 151 $ 23.33 Granted 123 24.66 Vested (15 ) 29.56 Forfeited — — Outstanding and unvested at March 31, 2016 259 $ 23.60
Shares Reserved for Future Issuance under the Stock Option Activity under the Equity Incentive Plans	The Company had the following ordinary shares reserved for future issuance under its equity incentive plans as of March 31, 2016 : Number of Shares (In thousands) Share options outstanding 2,976 Non-vested restricted share awards 767 Shares authorized for future issuance 3,017 ESPP shares available for future issuance 3,053 Total shares reserved for future issuance 9,813

Segment Information (Tables)

Segment Information (Tables)	3 Months Ended
	Mar. 31, 2016
Segment Reporting [Abstract]
Financial Performance of Reporting Segments	The following table summarizes the financial performance of the Company's reportable segments, including a reconciliation of income from segment operations to income from total operations: Three months ended March 31, 2016 March 31, 2015 Automation and Analytics Medication Adherence Total Automation and Analytics Medication Adherence Total (In thousands) Revenues $ 148,945 $ 22,059 $ 171,004 $ 92,779 $ 23,442 $ 116,221 Cost of revenues 77,207 13,852 91,059 38,852 15,684 54,536 Gross profit 71,738 8,207 79,945 53,927 7,758 61,685 Operating expenses 52,205 5,611 57,816 28,589 6,341 34,930 Income from segment operations $ 19,533 $ 2,596 $ 22,129 $ 25,338 $ 1,417 $ 26,755 Corporate costs 20,277 16,376 Income from operations $ 1,852 $ 10,379 ________________________________________________
Revenue by Geographical Location	Revenues Three months ended March 31, March 31, (In thousands) United States $ 143,493 $ 97,823 Rest of world (1) 27,511 18,398 Total revenues $ 171,004 $ 116,221 (1) No individual country represented more than 10% of the respective totals.
Long-lived Assets by Geographical Location	Property and equipment, net March 31, December 31, (In thousands) United States $ 38,880 $ 29,506 Rest of world (1) 3,328 2,803 Total property and equipment, net $ 42,208 $ 32,309 _________________________________________________ (1) No individual country represented more than 10% of the respective totals.

Organization and Summary of S32

Organization and Summary of Significant Accounting Policies - (Details)	3 Months Ended
	Mar. 31, 2016
Accounts Receivable
Concentration Risk [Line Items]
Number of significant customers that accounted for more than 10% of accounts receivables	0

Business Acquisitions - Additio

Business Acquisitions - Additional Information (Details) - USD ($) $ in Thousands	Jan. 05, 2016	Apr. 30, 2015	Apr. 30, 2015	Apr. 21, 2015	Mar. 31, 2016	Mar. 31, 2016	Dec. 31, 2015	Mar. 31, 2015
Business Acquisition [Line Items]
Cash consideration paid			$ 37,638			$ 271,458		$ 0
Cash on hand at signing		$ 3,789	3,789
Business combination, earn-out payment						3,000		$ 0
Aesynt Holding, L.P., Aesynt, Ltd.
Business Acquisition [Line Items]
Cash consideration paid	$ 271,458
Cash on hand at signing	8,164
Aggregate acquisition related costs	$ 5,200
Acquisition-related costs						2,300	$ 2,900
Revenue of acquiree since acquisition date					$ 43,200
Losses from acquiree since acquisition date					$ (9,500)
Aesynt Holding, L.P., Aesynt, Ltd. | In-process R&D
Business Acquisition [Line Items]
Royalty rate	12.50%
Aesynt Holding, L.P., Aesynt, Ltd. | Trade names
Business Acquisition [Line Items]
Royalty rate	0.50%
Aesynt Holding, L.P., Aesynt, Ltd. | Customer relationships
Business Acquisition [Line Items]
Discount rate	13.00%
Aesynt Holding, L.P., Aesynt, Ltd. | Backlog
Business Acquisition [Line Items]
Discount rate	10.00%
Aesynt Holding, L.P., Aesynt, Ltd. | Non-compete
Business Acquisition [Line Items]
Discount rate	13.00%
Aesynt Holding, L.P., Aesynt, Ltd. | Minimum
Business Acquisition [Line Items]
In process research and development, expected term	2 years
Aesynt Holding, L.P., Aesynt, Ltd. | Minimum | Developed technology
Business Acquisition [Line Items]
Royalty rate	0.40%
Aesynt Holding, L.P., Aesynt, Ltd. | Maximum
Business Acquisition [Line Items]
In process research and development, expected term	3 years
Aesynt Holding, L.P., Aesynt, Ltd. | Maximum | Developed technology
Business Acquisition [Line Items]
Royalty rate	0.80%
Mach4
Business Acquisition [Line Items]
Cash consideration paid				$ 16,889
Cash on hand at signing				397
Payment to acquire business, amount in cash after adjustments				17,300
Amount placed in escrow fund for business acquisition				$ 2,700
Revenue of acquiree since acquisition date						3,800
Losses from acquiree since acquisition date						(1,700)
Avantec
Business Acquisition [Line Items]
Cash consideration paid		20,749
Cash on hand at signing		$ 3,392	$ 3,392
Period after closing date to settle indemnification and other claims		18 months
Percentage of interest acquired		85.00%	85.00%
Payments to acquire business, gross		$ 12,000
Business acquisition, potential earn-out payment		5,600	$ 5,600
Business acquisition, amount withheld for indemnification		1,800	1,800
Business combination, earn-out payment						3,000
Revenue of acquiree since acquisition date						2,900
Losses from acquiree since acquisition date						$ 800
Avantec | Payable After December 31, 2015
Business Acquisition [Line Items]
Business acquisition, potential earn-out payment		3,000	3,000
Avantec | Payable After December 31, 2016
Business Acquisition [Line Items]
Business acquisition, potential earn-out payment		$ 3,000	$ 3,000

Business Acquisitions - Total P

Business Acquisitions - Total Purchase Price and Identifiable Intangible Assets (Details) - USD ($) $ in Thousands	Jan. 05, 2016	Apr. 30, 2015	Apr. 30, 2015	Apr. 21, 2015	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Total Purchase Price
Cash		$ 3,789	$ 3,789
Accounts receivable		7,350	7,350
Inventory		5,008	5,008
Deferred tax assets and other current assets		457	457
Total current assets		16,604	16,604
Property and equipment		463	463
Intangibles		14,051	14,051
Goodwill		26,197	26,197		$ 312,511		$ 147,906
Other non-current assets		52	52
Total assets		57,367	57,367
Current liabilities		7,809	7,809
Non-current deferred tax liabilities		3,833	3,833
Deferred service revenue and gross profit		3,242	3,242
Other non-current liabilities		1,056	1,056
Total purchase price		41,427	41,427
Total purchase price, net of cash received			37,638		$ 271,458	$ 0
Aesynt Holding, L.P., Aesynt, Ltd.
Total Purchase Price
Cash	$ 8,164
Accounts receivable	44,895
Inventory	20,111
Other current assets	4,381
Total current assets	77,551
Property and equipment	10,389
Intangibles	123,700
Goodwill	164,824
Other non-current assets	968
Total assets	377,432
Current liabilities	25,821
Deferred revenue, net	25,631
Non-current deferred tax liabilities	43,927
Other non-current liabilities	2,431
Total liabilities	97,810
Total purchase price	279,622
Total purchase price, net of cash received	271,458
Mach4
Total Purchase Price
Cash				$ 397
Accounts receivable				3,743
Inventory				3,580
Deferred tax assets and other current assets				368
Total current assets				8,088
Property and equipment				463
Intangibles				7,710
Goodwill				10,591
Other non-current assets				52
Total assets				26,904
Current liabilities				3,684
Non-current deferred tax liabilities				2,564
Deferred service revenue and gross profit				2,314
Other non-current liabilities				1,056
Total purchase price				17,286
Total purchase price, net of cash received				16,889
Identifiable Intangible Assets
Fair value of identifiable intangible assets purchased				7,710
Avantec
Total Purchase Price
Cash		3,392	3,392
Accounts receivable		3,607	3,607
Inventory		1,428	1,428
Deferred tax assets and other current assets		89	89
Total current assets		8,516	8,516
Property and equipment		0	0
Intangibles		6,341	6,341
Goodwill		15,606	15,606
Other non-current assets		0	0
Total assets		30,463	30,463
Current liabilities		4,125	4,125
Non-current deferred tax liabilities		1,269	1,269
Deferred service revenue and gross profit		928	928
Other non-current liabilities		0	0
Total purchase price		24,141	$ 24,141
Total purchase price, net of cash received		20,749
Identifiable Intangible Assets
Fair value of identifiable intangible assets purchased		6,341
In-process R&D | Aesynt Holding, L.P., Aesynt, Ltd.
Identifiable Intangible Assets
Indefinite-lived Intangible Assets Acquired	3,900
Customer relationships | Aesynt Holding, L.P., Aesynt, Ltd.
Identifiable Intangible Assets
Fair value of identifiable intangible assets purchased	58,200
Customer relationships | Mach4
Identifiable Intangible Assets
Fair value of identifiable intangible assets purchased				$ 3,570
Weighted average useful life (in years)				10 years
Customer relationships | Avantec
Identifiable Intangible Assets
Fair value of identifiable intangible assets purchased		$ 5,834
Weighted average useful life (in years)		12 years
Developed technology | Aesynt Holding, L.P., Aesynt, Ltd.
Identifiable Intangible Assets
Fair value of identifiable intangible assets purchased	$ 38,800
Weighted average useful life (in years)	8 years
Developed technology | Mach4
Identifiable Intangible Assets
Fair value of identifiable intangible assets purchased				$ 3,290
Weighted average useful life (in years)				8 years
Backlog | Aesynt Holding, L.P., Aesynt, Ltd.
Identifiable Intangible Assets
Fair value of identifiable intangible assets purchased	$ 20,200
Backlog | Avantec
Identifiable Intangible Assets
Fair value of identifiable intangible assets purchased		$ 415
Weighted average useful life (in years)		2 years
Non-compete | Aesynt Holding, L.P., Aesynt, Ltd.
Identifiable Intangible Assets
Fair value of identifiable intangible assets purchased	$ 1,800
Weighted average useful life (in years)	3 years
Trade names | Aesynt Holding, L.P., Aesynt, Ltd.
Identifiable Intangible Assets
Fair value of identifiable intangible assets purchased	$ 800
Weighted average useful life (in years)	1 year
Trade names | Mach4
Identifiable Intangible Assets
Fair value of identifiable intangible assets purchased				$ 850
Weighted average useful life (in years)				6 years
Trade names | Avantec
Identifiable Intangible Assets
Fair value of identifiable intangible assets purchased		$ 92
Weighted average useful life (in years)		2 years
Minimum | Customer relationships | Aesynt Holding, L.P., Aesynt, Ltd.
Identifiable Intangible Assets
Weighted average useful life (in years)	14 years
Minimum | Backlog | Aesynt Holding, L.P., Aesynt, Ltd.
Identifiable Intangible Assets
Weighted average useful life (in years)	1 year
Maximum | Customer relationships | Aesynt Holding, L.P., Aesynt, Ltd.
Identifiable Intangible Assets
Weighted average useful life (in years)	16 years
Maximum | Backlog | Aesynt Holding, L.P., Aesynt, Ltd.
Identifiable Intangible Assets
Weighted average useful life (in years)	3 years

Business Acquisitions - Pro For

Business Acquisitions - Pro Forma Information (Details) - Aesynt Holding, L.P., Aesynt, Ltd. - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Business Acquisition [Line Items]
Pro forma net revenues	$ 171,004	$ 159,614
Pro forma net income	$ (378)	$ (119)
Pro forma net income (loss) per share basic (in dollars per share)	$ (0.01)	$ 0
Pro forma net income (loss) per share diluted (in dollars per share)	$ (0.01)	$ 0

Net Income (Loss) Per Share -

Net Income (Loss) Per Share - (Basic and Diluted Net Income Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Earnings Per Share [Abstract]
Net income (loss)	$ (378)	$ 6,318
Weighted-average shares outstanding — basic (in shares)	35,740	36,024
Dilutive effect of employee stock plans (in shares)	0	890
Weighted-average shares outstanding — diluted (in shares)	35,740	36,914
Net income per share — basic (in dollars per share)	$ (0.01)	$ 0.18
Net income per share — diluted (in dollars per share)	$ (0.01)	$ 0.17
Anti-dilutive weighted-average shares related to stock award plans (in shares)	2,045	484

Cash and Cash Equivalents and37

Cash and Cash Equivalents and Fair Value of Financial Instruments - Assets Measured at Fair Value On A Recurring Basis (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market fund	$ 10,118	$ 10,114
Fair Value, Inputs, Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market fund	10,118	10,114
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash	43,369	72,103
Money market fund	10,118	10,114
Total cash and cash equivalents	$ 53,487	$ 82,217

Cash and Cash Equivalents and38

Cash and Cash Equivalents and Fair Value of Financial Instruments - Schedule of Financial Assets Measured At Fair Value (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market fund	$ 10,118	$ 10,114
Forward contracts	8	32
Total financial assets	10,126	10,146
Total financial liabilities	2,867	5,823
Fair Value, Inputs, Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market fund	10,118	10,114
Forward contracts	0	0
Total financial assets	10,118	10,114
Total financial liabilities	0	0
Fair Value, Inputs, Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market fund	0	0
Forward contracts	8	32
Total financial assets	8	32
Total financial liabilities	0	0
Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market fund	0	0
Forward contracts	0	0
Total financial assets	0	0
Total financial liabilities	2,867	5,823
Contingent Consideration Liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial liabilities	2,867	5,823
Contingent Consideration Liability | Fair Value, Inputs, Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial liabilities	0	0
Contingent Consideration Liability | Fair Value, Inputs, Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial liabilities	0	0
Contingent Consideration Liability | Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial liabilities	$ 2,867	$ 5,823

Cash and Cash Equivalents and39

Cash and Cash Equivalents and Fair Value of Financial Instruments - Foreign Currency Risk Management (Details) - Foreign Exchange Forward - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Derivatives, Fair Value [Line Items]
Derivative, notional amount	$ 0.3	$ 0.4
Fair Value, Inputs, Level 2
Derivatives, Fair Value [Line Items]
Aggregate fair value of outstanding derivative, less than	$ 0.1	$ 0.1

Balance Sheet Components (Detai

Balance Sheet Components (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Inventories:
Raw materials	$ 17,623	$ 11,582
Work in process	7,062	1,653
Finished goods	47,229	33,359
Total inventories	71,914	46,594
Property and equipment:
Equipment	68,335	43,533
Furniture and fixtures	8,314	5,897
Leasehold improvements	14,955	9,063
Software	35,399	30,693
Construction in progress	5,408	3,651
Property and equipment, gross	132,411	92,837
Accumulated depreciation and amortization	(90,203)	(60,528)
Total property and equipment, net	42,208	32,309
Other long term assets:
Capitalized software, net	27,130	26,011
Other assets	1,679	1,883
Total other long term assets, net	28,809	27,894
Accrued liabilities:
Advance payments from customers	7,443	8,327
Rebates and lease buyouts	4,384	4,702
Group purchasing organization fees	2,493	2,983
Taxes payable	2,722	2,768
Other accrued liabilities	17,861	11,353
Total accrued liabilities	$ 34,903	$ 30,133

Investment in Sales-Type Leas41

Investment in Sales-Type Leases, Net - Long Term Net Investment in Sales Type Leases (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Capital Leased Assets [Line Items]
Minimum lease payments to be received, net	$ 32,541	$ 22,255
Less: Unearned interest income portion	(2,470)	(1,014)
Investment in sales-type leases, net	30,071	21,241
Less: short-term portion	(9,034)	(6,757)
Long-term investment in sales-type leases, net	21,037	14,484
Collective allowance for credit losses	$ 300	$ 200
Minimum
Capital Leased Assets [Line Items]
Terms of sales-type leases (generally up to five years in length)	1 year
Maximum
Capital Leased Assets [Line Items]
Terms of sales-type leases (generally up to five years in length)	5 years

Investment in Sales-Type Leas42

Investment in Sales-Type Leases, Net - Capital Leases, Future Minimum Payments Receivable (Details) $ in Thousands	Mar. 31, 2016USD ($)
Leases [Abstract]
Remaining nine months of 2016	$ 7,253
2,017	9,126
2,018	7,328
2,019	5,032
2,020	3,200
Thereafter	602
Total	$ 32,541

Goodwill and Intangible Asset43

Goodwill and Intangible Assets - Carrying Amount of Goodwill (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2016USD ($)
Goodwill [Roll Forward]
Net balance as of December 31, 2015	$ 147,906
Foreign currency exchange rate fluctuations	(219)
Net balance as of March 31, 2016	312,511
Automation and Analytics
Goodwill [Roll Forward]
Net balance as of December 31, 2015	54,316
Foreign currency exchange rate fluctuations	77
Net balance as of March 31, 2016	219,217
Medication Adherence
Goodwill [Roll Forward]
Net balance as of December 31, 2015	93,590
Foreign currency exchange rate fluctuations	(296)
Net balance as of March 31, 2016	93,294
Mach4
Goodwill [Roll Forward]
Goodwill acquired	164,824
Mach4 | Automation and Analytics
Goodwill [Roll Forward]
Goodwill acquired	$ 164,824

Goodwill and Intangible Asset44

Goodwill and Intangible Assets - Intangible Assets, Net (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross Carrying Amount		$ 110,851
Intangible Assets, Accumulated Amortization	$ (26,388)	(20,501)
Intangible Assets, Foreign Currency Exchange Rate Fluctuations	(629)	(685)
Total Intangibles Assets, Net Carrying Amount	202,361	89,665
Intangible Assets, Gross (Excluding Goodwill)	233,278
Intangible assets, net	206,261	89,665
Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross Carrying Amount	126,338	69,554
Intangible Assets, Accumulated Amortization	(11,656)	(11,315)
Intangible Assets, Foreign Currency Exchange Rate Fluctuations	(818)	(719)
Total Intangibles Assets, Net Carrying Amount	113,864	57,520
Acquired technology
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross Carrying Amount	70,041	30,870
Intangible Assets, Accumulated Amortization	(7,850)	(6,088)
Intangible Assets, Foreign Currency Exchange Rate Fluctuations	173	59
Total Intangibles Assets, Net Carrying Amount	62,364	24,841
Trade names
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross Carrying Amount	8,542	8,052
Intangible Assets, Accumulated Amortization	(2,672)	(2,551)
Intangible Assets, Foreign Currency Exchange Rate Fluctuations	36	(14)
Total Intangibles Assets, Net Carrying Amount	5,906	5,487
Patents
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross Carrying Amount	2,042	1,960
Intangible Assets, Accumulated Amortization	(407)	(384)
Intangible Assets, Foreign Currency Exchange Rate Fluctuations	0	0
Total Intangibles Assets, Net Carrying Amount	1,635	1,576
Backlog
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross Carrying Amount	20,615	415
Intangible Assets, Accumulated Amortization	(3,653)	(163)
Intangible Assets, Foreign Currency Exchange Rate Fluctuations	(20)	(11)
Total Intangibles Assets, Net Carrying Amount	16,942	$ 241
Useful Life (Years)		2 years
Non-compete agreements
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross Carrying Amount	1,800
Intangible Assets, Accumulated Amortization	(150)
Total Intangibles Assets, Net Carrying Amount	$ 1,650
Useful Life (Years)	3 years
Minimum | Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Useful Life (Years)	5 years	5 years
Minimum | Acquired technology
Acquired Finite-Lived Intangible Assets [Line Items]
Useful Life (Years)	3 years	3 years
Minimum | Trade names
Acquired Finite-Lived Intangible Assets [Line Items]
Useful Life (Years)	1 year	1 year
Minimum | Patents
Acquired Finite-Lived Intangible Assets [Line Items]
Useful Life (Years)	2 years	2 years
Minimum | Backlog
Acquired Finite-Lived Intangible Assets [Line Items]
Useful Life (Years)	1 year
Maximum | Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Useful Life (Years)	30 years	30 years
Maximum | Acquired technology
Acquired Finite-Lived Intangible Assets [Line Items]
Useful Life (Years)	20 years	20 years
Maximum | Trade names
Acquired Finite-Lived Intangible Assets [Line Items]
Useful Life (Years)	12 years	12 years
Maximum | Patents
Acquired Finite-Lived Intangible Assets [Line Items]
Useful Life (Years)	20 years	20 years
Maximum | Backlog
Acquired Finite-Lived Intangible Assets [Line Items]
Useful Life (Years)	3 years
In-process Technology
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill)	$ 3,900

Goodwill and Intangible Asset45

Goodwill and Intangible Assets - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense of intangible assets	$ 9.2	$ 1.3

Goodwill and Intangible Asset46

Goodwill and Intangible Assets - Future Amortization Expense for Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Remaining nine months of 2016	$ 27,031
2,017	22,834
2,018	21,221
2,019	16,143
2,020	15,138
Thereafter	99,994
Total Intangibles Assets, Net Carrying Amount	$ 202,361	$ 89,665

Debt Narrative (Details)

Debt Narrative (Details) - USD ($)	Jan. 05, 2016	Mar. 31, 2016
Debt Instrument [Line Items]
Deferred issuance cost, gross	$ 7,900,000
Wells Fargo Bank, National Association
Debt Instrument [Line Items]
Proceeds from lines of credit		$ 255,000,000
Wells Fargo Bank, National Association | Secured Debt | Line of Credit
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 400,000,000
Wells Fargo Bank, National Association | Secured Debt | Line of Credit | Credit Agreement, Interest Rate Option Two | Federal Funds Rate
Debt Instrument [Line Items]
Basis spread on variable rate	0.50%
Wells Fargo Bank, National Association | Revolving Credit Facility
Debt Instrument [Line Items]
Proceeds from lines of credit		55,000,000
Wells Fargo Bank, National Association | Revolving Credit Facility | Line of Credit
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 200,000,000
Proceeds from lines of credit	$ 55,000,000
Debt instrument, term	5 years
Wells Fargo Bank, National Association | Term Loan Facility
Debt Instrument [Line Items]
Proceeds from lines of credit		$ 200,000,000
Wells Fargo Bank, National Association | Term Loan Facility | Line of Credit
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 200,000,000
Proceeds from lines of credit	$ 200,000,000
Debt instrument, term	5 years
Principal periodic payment, percent, years one and two	5.00%
Principal periodic payment, percent, years three and four	10.00%
Principal periodic payment, percent, year five	15.00%
Wells Fargo Bank, National Association | Letter of Credit
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 10,000,000
Wells Fargo Bank, National Association | Bridge Loan
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 10,000,000
Minimum | Wells Fargo Bank, National Association | Secured Debt | Line of Credit | Credit Agreement, Interest Rate Option One | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Basis spread on variable rate	1.50%
Minimum | Wells Fargo Bank, National Association | Secured Debt | Line of Credit | Credit Agreement, Interest Rate Option Two | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Basis spread on variable rate	0.50%
Minimum | Wells Fargo Bank, National Association | Revolving Credit Facility | Line of Credit
Debt Instrument [Line Items]
Unused capacity, percentage	0.20%
Minimum | Wells Fargo Bank, National Association | Letter of Credit | Line of Credit
Debt Instrument [Line Items]
Commitment fee percentage	1.50%
Maximum | Wells Fargo Bank, National Association | Secured Debt | Line of Credit | Credit Agreement, Interest Rate Option One | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Basis spread on variable rate	2.25%
Maximum | Wells Fargo Bank, National Association | Secured Debt | Line of Credit | Credit Agreement, Interest Rate Option Two | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Basis spread on variable rate	1.25%
Maximum | Wells Fargo Bank, National Association | Revolving Credit Facility | Line of Credit
Debt Instrument [Line Items]
Unused capacity, percentage	0.35%
Maximum | Wells Fargo Bank, National Association | Letter of Credit | Line of Credit
Debt Instrument [Line Items]
Commitment fee percentage	2.25%

Debt Components of Debt (Detail

Debt Components of Debt (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Long-term Debt [Roll Forward]
Repayment of debt under revolving credit facility	$ (20,000)	$ 0
Amortization of deferred issuance cost	397	$ 0
Long term debt, current portion, net of deferred issuance cost	8,410		$ 0
Long term debt, net of deferred issuance cost	219,046		$ 0
Wells Fargo Bank, National Association
Long-term Debt [Roll Forward]
Long-term Line of Credit	0
Long-term Debt	0
Proceeds from lines of credit	255,000
Deferred issuance cost, gross	(7,949)
Line of Credit Facility, Increase, Borrowings Net Of Financing Costs	247,051
Repayment of debt under revolving credit facility	(20,000)
Amortization of deferred issuance cost	397
Debt Instrument, Decrease, Repayments Net of Amortization	(19,603)
Long-term Line of Credit	235,000
Deferred issuance cost, net	(7,552)
Long-term Debt	227,448
Long term debt, current portion, net of deferred issuance cost	8,410
Long term debt, net of deferred issuance cost	219,038
Wells Fargo Bank, National Association | Term Loan Facility
Long-term Debt [Roll Forward]
Long-term Line of Credit	0
Proceeds from lines of credit	200,000
Repayment of debt under revolving credit facility	0
Long-term Line of Credit	200,000
Wells Fargo Bank, National Association | Revolving Credit Facility
Long-term Debt [Roll Forward]
Long-term Line of Credit	0
Proceeds from lines of credit	55,000
Repayment of debt under revolving credit facility	(20,000)
Long-term Line of Credit	$ 35,000

Deferred revenue - Additional

Deferred revenue - Additional Information (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Revenue Recognition [Abstract]
Deferred service revenue, cost of sales, current	$ (19,000)	$ (15,700)
Deferred service revenue, noncurrent portion	$ 17,820	$ 17,975

Commitments and Contingencies -

Commitments and Contingencies - Minimum Future Payments on Non-Cancelable Operating Leases (Details) $ in Thousands	Mar. 31, 2016USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remaining nine months of 2016	$ 7,996
2,017	10,441
2,018	9,921
2,019	9,802
2,020	6,256
Thereafter	10,870
Total minimum future lease payments	55,286
Purchase obligation due within the next twelve months	$ 38,900

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Annual effective tax rate	37.00%	38.60%
Statutory income tax rate	35.00%		35.00%
Unrecognized tax benefits	$ 9.9		$ 7.2
Accrued interest and penalties	$ 1		$ 0.2

Employee Benefits and Share-B52

Employee Benefits and Share-Based Compensation - Shared-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 3,891	$ 3,665
Cost of product and service revenues
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	549	517
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	641	434
Selling, general and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 2,701	$ 2,714

Employee Benefits and Share-B53

Employee Benefits and Share-Based Compensation - Valuation of Share Based Awards, Table (Details)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life, years	4 years 10 months 31 days	5 years 15 days
Expected volatility, %	32.60%	33.20%
Risk free interest rate, %	1.40%	1.66%
Estimated forfeiture rate %	8.60%	2.50%
Dividend yield, %	0.00%	0.00%
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility, %, Min	25.79%	28.52%
Expected volatility, %, Max	34.79%	37.53%
Risk free interest rate, %, Min	0.26%	0.03%
Risk free interest rate, %, Max	0.79%	0.53%
Dividend yield, %	0.00%	0.00%
Minimum | Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life, years	6 months	6 months
Maximum | Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life, years	2 years	2 years

Employee Benefits and Share-B54

Employee Benefits and Share-Based Compensation - Stock Option Activity (Details) - 2009 Plan - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Number of Shares
Outstanding at December 31, 2015 (in shares)	2,688
Granted (in shares)	376
Exercised (in shares)	(49)
Expired (in shares)	(1)
Forfeited (in shares)	(38)
Outstanding at March 31, 2016 (in shares)	2,976		2,688
Exercisable at March 31, 2016 (in shares)	1,478
Vested and expected to vest at March 31, 2016 (in shares)	2,790
Weighted Average Exercise Price
Outstanding at December 31, 2015 (in dollars per share)	$ 22.89
Granted (in dollars per share)	27.75
Exercised (in dollars per share)	13.48
Expired (in dollars per share)	19.96
Forfeited (in dollars per share)	28.51
Outstanding at March 31, 2016 (in dollars per share)	23.59		$ 22.89
Exercisable at March 31, 2016 (in dollars per share)	18.53
Vested and expected to vest at March 31, 2016 (in dollars per share)	$ 23.23
Weighted-average remaining years, outstanding (in years)	7 years 1 day		6 years 10 months 20 days
Weighted-average remaining years, exercisable at March 31, 2016 (in years)	5 years
Weighted-average remaining years, vested and expected to vest at March 31, 2016 (in years)	6 years 10 months 24 days
Aggregate Intrinsic Value, outstanding at March 31, 2016	$ 15,891
Aggregate Intrinsic Value, exercisable at March 31, 2016	14,329
Aggregate Intrinsic Value, vested and expected to vest at March 31, 2016	$ 15,806
Employee Stock Option
Weighted Average Exercise Price
Weighted-average fair value (in dollars per share)	$ 8.51	$ 9.82
Intrinsic value of options exercised	$ 700	$ 2,400
Unrecognized compensation cost of unvested stock options	$ 11,300
Weighted average period of compensation cost recognized	3 years 20 days

Employee Benefits and Share-B55

Employee Benefits and Share-Based Compensation - Restricted Stock Activity (Details) - 2009 Plan - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Number of Shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	$ 23.23
Restricted Stock Units (RSUs)
Number of Shares
Outstanding at December 31, 2015 (in shares)	417
Granted (in shares)	90
Vested (in shares)	(23)
Forfeited (in shares)	(7)
Outstanding and unvested at March 31, 2016 (in shares)	477		417
Expected to vest after March 31, 2016 (in shares)	419
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	$ 28.39
Weighted-Average Grant Date Fair Value
Outstanding and unvested (in dollars per share)	28.49
Granted (in dollars per share)	27.77	$ 33.97
Vested (in dollars per share)	25.76
Forfeited (in dollars per share)	28.42
Outstanding and unvested (in dollars per share)	$ 28.49		$ 28.49
Weighted-average remaining years, expected to vest after March 31, 2016 (in years)	1 year 5 months
Weighted-average remaining years, outstanding and unvested (in years)	1 year 6 months		1 year 7 months
Aggregate Intrinsic Value
Outstanding and unvested at March 31, 2016	$ 13,292
Expected to vest after March 31, 2016	11,677
Unrecognized compensation expense	$ 10,700
Restricted Stock Awards
Number of Shares
Outstanding at December 31, 2015 (in shares)	31
Granted (in shares)	0
Vested (in shares)	0
Forfeited (in shares)	0
Outstanding and unvested at March 31, 2016 (in shares)	31		31
Weighted-Average Grant Date Fair Value
Outstanding and unvested (in dollars per share)	$ 35.98
Granted (in dollars per share)	0
Vested (in dollars per share)	0
Forfeited (in dollars per share)	0
Outstanding and unvested (in dollars per share)	$ 35.98		$ 35.98
Aggregate Intrinsic Value
Unrecognized compensation expense	$ 100
Weighted average period of compensation cost recognized	2 months 24 days

Employee Benefits and Share-B56

Employee Benefits and Share-Based Compensation - Performance Based Restricted Stock Unit Activity (Details) - 2009 Plan - Performance Shares [Member] - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Number of Shares
Outstanding at December 31, 2015 (in shares)	151
Granted (in shares)	123
Vested (in shares)	(15)
Canceled (in shares)	0
Outstanding and unvested at March 31, 2016 (in shares)	259
Weighted-Average Grant Date Fair Value Per Share
Outstanding and unvested (in dollars per share)	$ 23.33
Granted (in dollars per share)	24.66	$ 29.56
Vested (in dollars per share)	29.56
Canceled (in dollars per share)	0
Outstanding and unvested (in dollars per share)	$ 23.60
Unrecognized compensation cost	$ 3.2
Weighted average period of compensation cost recognized	1 year 5 months 24 days

Employee Benefits and Share-B57

Employee Benefits and Share-Based Compensation - Employee Stock Purchase Plan (ESPP) Activity (Details) $ in Millions	Mar. 31, 2016USD ($)
1997 Employee Stock Purchase Plan | Employee Stock Purchase Plan
Share-Based Arrangements with Employees and Nonemployees [Line Items]
Unrecognized compensation cost	$ 7.1

Employee Benefits and Share-B58

Employee Benefits and Share-Based Compensation - Summary of Shares Reserved for Future Issuance Under Equity Incentive Plans (Details) shares in Thousands	Mar. 31, 2016shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares reserved for future issuance	9,813
Share options outstanding
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares reserved for future issuance	2,976
Non-vested restricted share awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares reserved for future issuance	767
Shares authorized for future issuance
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares reserved for future issuance	3,017
ESPP shares available for future issuance
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares reserved for future issuance	3,053

Segment Information - Addition

Segment Information - Additional Information (Details) - segment	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Concentration Risk [Line Items]
Number of reportable segments	2
Number of segments	2
Sales Revenue, Net
Concentration Risk [Line Items]
Number of significant customers that accounted for more than 10% of accounts receivables	0	0
Number of countries that accounted for more that 10% of respective totals	0.00%	0.00%
Property, Plant and Equipment
Concentration Risk [Line Items]
Number of countries that accounted for more that 10% of respective totals	0.00%	0.00%

Segment Information - Financia

Segment Information - Financial Performance of Reporting Segments (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Segment Reporting Information [Line Items]
Property and equipment, net	$ 42,208		$ 32,309
Revenues	171,004	$ 116,221
Revenues	171,004	116,221
Cost of revenues	91,059	54,536
Gross profit	79,945	61,685
Operating expenses	78,093	51,306
Income from operations	1,852	10,379
Operating segments
Segment Reporting Information [Line Items]
Revenues	171,004	116,221
Cost of revenues	91,059	54,536
Gross profit	79,945	61,685
Operating expenses	57,816	34,930
Income from operations	22,129	26,755
Operating segments | Automation and Analytics
Segment Reporting Information [Line Items]
Revenues	148,945	92,779
Cost of revenues	77,207	38,852
Gross profit	71,738	53,927
Operating expenses	52,205	28,589
Income from operations	19,533	25,338
Operating segments | Medication Adherence
Segment Reporting Information [Line Items]
Revenues	22,059	23,442
Cost of revenues	13,852	15,684
Gross profit	8,207	7,758
Operating expenses	5,611	6,341
Income from operations	2,596	1,417
Corporate cost
Segment Reporting Information [Line Items]
Operating expenses	20,277	16,376
United States
Segment Reporting Information [Line Items]
Property and equipment, net	38,880		29,506
Revenues	143,493	97,823
Rest of world
Segment Reporting Information [Line Items]
Property and equipment, net	3,328		$ 2,803
Revenues	$ 27,511	$ 18,398

Subsequent Events - (Details)

Subsequent Events - (Details) - Subsequent Event $ in Millions	1 Months Ended	3 Months Ended
	May. 06, 2016Employee	Jun. 30, 2016USD ($)
Subsequent Event [Line Items]
Reduction in headcount, number of employees | Employee	34
Forecast | Employee Severance
Subsequent Event [Line Items]
Restructuring charges | $		$ 1.5